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Abstract 
INTRODUCTION: Initial examination of treatment worries suggest they may represent an 
important construct; however, previously used measures were limited by their specificity, scale 
format, and lack of parent report. Therefore the present study sought to examine the initial 
outcomes and psychometrics of newly developed corresponding measures of treatment worries 
in youth (Treatment Worries Questionnaire – Child; TWQ-C) and their parents (Treatment 
Worries Questionnaire – Parent; TWQ-P).  
METHODS: Participants were 94 youth (7-17-years old) and parent dyads presenting for 
psychosocial treatment of an anxiety disorder. Prior to initiation of treatment, dyads completed 
the TWQ-C and TWQ-P along with a host of additional child and parent report measures, and 
three clinician-rated measures.  
RESULTS: Treatment worries were endorsed in the mild-moderate range by youth and the 
TWQ-C demonstrated good-excellent internal consistency and test-retest reliability, a strong 
three-factor structure, and consistent convergent and divergent relationships. Treatment worries 
were endorsed in the low mild range by parents and the TWQ-P demonstrated fair-good internal 
consistency and test-retest reliability, a less empirically, but theoretically, supported four-factor 
structure, and consistent divergent relationships, but variable (by factor) convergent 
relationships.  
DISCUSSION: The results of the present study provide information on the concept of treatment 
worries and support the use of the TWQ-C and TWQ-P as broad assessments of the concept in a 
variety of populations. Low endorsement of worries among parents likely relates to the nature of 
 vi 
the present sample (treatment-seeking) and may have contributed significantly to the less ideal 
psychometrics of the TWQ-P in comparison to the TWQ-C. Future investigation of treatment 
worries using the TWQ-C and TWQ-P in a variety of samples is warranted.   
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Introduction 
 Anxiety disorders are a category of mental disorders that are characterized by excessive 
recurrence of anxiety, fear, and/or worry that manifests physically, cognitively and emotionally. 
Of psychiatric disorder classes (e.g., mood disorders, behavior disorders), anxiety disorders are 
the most common, with an estimated lifetime prevalence of 29 – 38% (Kessler et al., 2005; 
Merikangas et al., 2010), a predictive cumulative prevalence of 10% and 21% before the age of 
16 and 21 years respectively (Copeland, Shanahan, Costello, & Angold, 2011; Costello, 
Mustillo, Erkanli, Keeler, & Angold, 2003), as well as a point prevalence in youth estimated as 
low as 2% (3-month; Costello et al., 2003) and as high as 15% (30-day; Kessler et al., 2012). 
Most broadly, the classification of anxiety disorders includes agoraphobia, generalized anxiety 
disorder (GAD), obsessive-compulsive disorder (OCD), panic disorder (PD), post-traumatic 
stress disorder (PTSD), separation anxiety disorder (SAD), social phobia (SoP), and 
specific/simple phobia (SP). However, composition of what diagnoses should all be included 
under the classification or anxiety disorders has been debated, particularly in regards to 
obsessive-compulsive disorder, which has a unique connection to a number of other psychiatric 
disorders (e.g., tic disorders, body dysmorphic disorder; Hollander, Braun, & Simeon, 2008), and 
post-traumatic stress disorder, which, unlike the other anxiety disorders, is dependent on a 
specific traumatic trigger (Bodkin, Pope, Detke, & Hudson, 2007). As is true of psychopathology 
in general, co-occurrence amongst anxiety disorders is common, with approximately 15% of 
youth with anxiety disorders meeting diagnostic criteria for two anxiety diagnoses, and 5% 
having three or more (Ford, Goodman, & Meltzer, 2003; Lewinsohn, Zinbarg, Seeley, 
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Lewinsohn, & Sack, 1997). Further, in youth, anxiety disorders commonly co-occur with 
depressive disorders and disruptive disorders (27%; Ford et al., 2003).  
Without treatment, anxiety disorders are highly persistent and chronic, characterized by 
waxing and waning in symptoms, frequent relapse, and considerable fluctuation across anxiety 
diagnoses through life (Bruce et al., 2005; Wittchen, Lieb, Pfister, & Schuster, 2000). Anxiety 
disorders have consistently been shown to contribute to significant functional impairment and 
overall reductions in quality of life for youth (Essau, Conradt, & Petermann, 2000; Langley, 
Bergman, McCracken, & Piacentini, 2004; Langley et al., 2013). While areas of impairment may 
differ as a function of the specific diagnosis, studies have noted anxiety disorders contribute to 
problems in: A) educational and occupational functioning, including reduced achievement 
(Mychailyszyn, Mendez, & Kendall, 2010) and premature school withdrawal (Van Ameringen, 
Mancini, & Farvolden, 2003); B) social functioning (Ginsburg, La Greca, & Silverman, 1998; 
Strauss, Lease, Kazdin, Dulcan, & Last, 1989), including poorer peer interactions (Ginsburg et 
al., 1998); C) emotional functioning (Ginsburg et al., 1998), including lower self-esteem 
(Ehntholt, Salkovskis, & Rimes, 1999; Ginsburg et al., 1998); D) family life and daily living 
(Piacentini, Bergman, Keller, & McCracken, 2003); and E) health and wellness (Marciniak, 
Lage, Landbloom, Dunayevich, & Bowman, 2004), including increased sleep related problems 
(Alfano, Ginsburg, & Kingery, 2007; Storch, Murphy, et al., 2008). In addition, if untreated, 
onset of anxiety disorders in childhood is associated with increased risk for early parenthood, as 
well as the onset of other mental disorders (i.e., depression, substance use; Beesdo et al., 2007; 
Woodward & Fergusson, 2001; Zimmermann et al., 2003) and medical illnesses (e.g., cardiac 
disorders, hypertension; Harter, Conway, & Merikangas, 2003) later in life. These factors, 
combined with the frequency at which anxiety disorders occur, contribute to an immense societal 
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cost attributable to the presence of anxiety disorders (Bodden, Dirksen, & Bögels, 2007; 
Greenberg et al., 1999). Therefore, early and effective intervention for anxiety disorders is of 
considerable importance.  
 
Cognitive Behavioral Treatment of Anxiety Disorders 
 Despite the chronic and impairing nature of anxiety disorders if left untreated, a large 
body of evidence supports the effectiveness of cognitive-behavioral therapy (CBT) for treating 
anxiety in youth (Abramowitz, Whiteside, & Deacon, 2005; Cartwright-Hatton, Roberts, 
Chitsabesan, Fothergill, & Harrington, 2004; In-Albon & Schneider, 2007). While other 
treatments also have received empirical support (e.g., selective serotonin reuptake inhibitors 
(SSRIs) for OCD and GAD; PRN benzodiazepines for SP; Ravindran & Stein, 2010), CBT is 
considered the first-line treatment over these options due to comparable or superior treatment 
effects, increased durability, reduced cost, and minimal risk for adverse effects (Canton, Scott, & 
Glue, 2012; Eddy, Dutra, Bradley, & Westen, 2004; Heuzenroeder et al., 2004; Mitte, 2005a, 
2005b).  
The specific content and composition of CBT can differ across disorders, as well as 
across protocols; however, universally, CBT functions as a time-limited (6-16 sessions) 
treatment approach aimed at reducing the severity of anxiety symptoms. While neurobiological 
factors are not ignored, under the CBT model, anxiety symptoms are viewed as the result of a 
cycle between thoughts, feelings (i.e., physical response) and behaviors. Contact with feared 
stimuli generate anxiogenic cognitions and a heightened physiological response, which 
individuals attempt to reduce through the use of compensatory behaviors (e.g., compulsions, 
avoidance). Temporarily successful, the use of these behaviors reinforces the fear response and 
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often become more extensive or complicated over time. Therefore, CBT involves strategies 
aimed at helping individuals learn a new non-fear relationship with feared stimuli. 
In general, CBT is comprised of two major components, one cognitive and one 
behavioral, as well as introduction (psychoeducation) and termination (relapse prevention) 
material. Functioning as an introduction to treatment, CBT first involves the provision of 
educational material to families on the nature of anxiety symptomology and phenomenology, as 
well as the framework, content, requirements and efficacy for CBT. The function of 
psychoeducation is to establish rapport, address potential misbeliefs, and set up realistic 
expectations regarding efficacy, motivation, attendance, and homework/treatment completion 
(Steketee et al., 2011; Westra, Dozois, & Marcus, 2007). Once psychoeducation has been 
completed, either the behavioral or cognitive component is introduced. For anxiety disorders, the 
behavioral component of CBT involves the implementation of exposures. Appropriate exposures 
are developed through a collaborative process between the patient and therapist in which feared 
situations or stimuli are ranked according to the perceived difficulty. This list, or fear hierarchy, 
is then used as a guide for engaging in gradually intensifying exposures. When completing an 
exposure, the patient faces the identified trigger while resisting the prototypical safety response 
(e.g., compulsions, avoidance). Individuals naturally habituate to anxiety and, with repeated 
practice, reduce and ultimately eliminate the fear-response. Cognitive strategies, the second core 
component of CBT, typically focus on helping individuals identify positive and negative 
emotions (i.e., affective education) and challenging/combating distorted/anxiogenic thoughts 
(i.e., cognitive restructuring). At the termination of treatment, families are educated regarding 
potential relapse and strategies that can be useful in maintaining treatment gains.  
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Factors Associated with CBT Obtainment and Response 
 While largely effective, a percentage of individuals who receive CBT do not improve or 
demonstrate a treatment response (In-Albon & Schneider, 2007) and even those who do, 
frequently finish treatment with residual symptoms (e.g., Walkup et al., 2008). Despite this, 
relatively few studies have investigated clinical factors that may contribute to response and those 
studies that have, are often specific to OCD. However, this limited research does suggest several 
factors, including symptom presentation, comorbidity, family accommodation, insight, and 
treatment expectancies, that appear to impact treatment response (Storch, Bjorgvinsson, et al., 
2010). In particular, the latter three characteristics are of interest as they appear to contribute to 
poorer treatment response in a similar way via reductions in treatment motivation and adherence 
(Storch, Bjorgvinsson, et al., 2010).  
 Family Accommodation. Theoretically, high levels of family accommodation contribute 
to the maintenance and escalation of a child’s anxiety both indirectly (i.e., allowing symptoms to 
progress unhindered by parental restrictions), as well as directly, (i.e., aiding in completion of 
reinforcing behaviors; Lebowitz, Panza, Su, & Bloch, 2012; Lebowitz et al., 2013). These 
patients, and their parents, may be reluctant to reduce accommodating behaviors, which are 
perceived to help reduce child distress and impairment (Peris et al., 2008; Storch, Geffken, 
Merlo, Jacob, et al., 2007) and may as a result undermine therapeutic tasks through continued 
accommodation. Not surprisingly then, high levels of family accommodation are associated with 
reduced treatment response (Garcia et al., 2010; Merlo, Lehmkuhl, Geffken, & Storch, 2009) and 
poorer long-term outcomes (Barrett, Farrell, Dadds, & Boulter, 2005).  
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 Insight. Youth with poor insight tend to view their symptoms, even though distressing, as 
necessary or beneficial, rather than problematic, and have difficulty understanding the self-
maintaining nature of their symptoms (O'Dwyer & Marks, 2000). These individuals tend to have 
more severe symptoms (Storch, Milsom, et al., 2008) and demonstrate reduced symptom-
challenging behaviors (Catapano, Sperandeo, Perris, Lanzaro, & Maj, 2001). Poor insight 
reduces youths’ understanding of why they are in treatment or how it will be beneficial, and as a 
result, these youth tend to display poorer motivation for, and compliance with, treatment, 
ultimately leading to a reduced treatment response (Catapano et al., 2001; Lewin et al., 2010; 
Storch, Bjorgvinsson, et al., 2010).  
Treatment Expectancies. More broadly examined than family accommodation and patient 
insight, treatment expectancies have been repeatedly identified as a factor contributing to patient 
success in psychotherapy (Constantino, Arnkoff, Glass, Ametrano, & Smith, 2011). In particular, 
individuals who demonstrate realistic, but tempered expectancies for therapy exhibit more robust 
therapeutic response when compared with individuals who either: A) do not expect treatment to 
work; or B) expect treatment to be extremely successful/fast acting (Constantino et al., 2011; 
Dew & Bickman, 2005; Westra, Aviram, Barnes, & Angus, 2010; Westra et al., 2007). 
Theoretically, this window of expectancies keeps individuals motivated, through a combination 
of optimism (that treatment will work) and realism (that treatment will be difficult). 
 
Worries About Treatment  
 Clinical experience and preliminary research suggest that many individuals who are 
about to begin treatment may be worried or concerned about doing so. These worries may focus 
on what treatment will involve/require and what may occur as a result of treatment. While 
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worries and concerns are likely present across diagnostic conditions and treatment approaches, 
youth (and their parents) seeking CBT for anxiety disorders may be a particularly susceptible 
population to this phenomenon. For one, these youth are anxious and therefore may generalize 
their anxiety towards therapy and what it may require. Similarly, parents of youth with anxiety 
disorders also frequently have high level of anxiety (Burstein, Ginsburg, & Tein, 2010; 
Silverman, Cerny, Nelles, & Burke, 1988) and may be similarly wary of treatment. As discussed 
above, the nature of CBT for anxiety disorders (i.e., youth gradually face their fears and reduce 
their use of coping behaviors, such as compulsions and avoidance) may be a particularly 
frightening prospect for youth, as well as their parents. Therefore, one could hypothesize that a 
number of youth with anxiety and their parents have worries about beginning CBT for anxiety.  
Hypothetically, worries or concerns about beginning treatment could function in a similar 
way, and be highly related, to the factors discussed above. It seems likely that, if pervasive, these 
worries could impact treatment motivation, compliance and outcomes. For example, if a child is 
particularly worried that therapy might be difficult, embarrassing, and will not work, s/he may be 
reluctant to open up to the therapist or complete therapeutic tasks. Similarly, parents who are 
worried that their child may become highly distressed in treatment or won’t get better, may not 
ensure completion of therapeutic homework or may balk on attending sessions. It also seems 
likely that treatment worries may interact with clinical characteristics like family accommodation 
(e.g., families who highly accommodate symptoms may be apprehensive to reduce these 
behaviors), insight (e.g., individuals who have limited insight may be highly concerned about 
what therapy will require them to change about their symptoms) and treatment expectancies 
(e.g., individuals who do not expect treatment to work may have doubts about starting it). 
Despite this, relatively few data exist on the nature, extent and impact of treatment fears.  
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 Using qualitative answers obtained from 95 adults with a principal anxiety disorder, 
Purdon, Rowa, and Antony (2005) collected the first information regarding what concerns 
individuals may have regarding starting behavioral treatment. Based on this initial data, Rowa et 
al. (2014) developed a self-report measure of treatment concerns for adults, named the Treatment 
Ambivalence Questionnaire that was subsequently examined in a sample of 628 anxiety-
disordered adults. The results of Rowa et al. (2014) indicate that many adults obtaining treatment 
for anxiety disorders have concerns and worries regarding beginning behavioral treatment. In 
particular, factor analysis of the TAQ indicated individuals endorsed concerns regarding: A) 
experiencing personal consequences as a result of participating in treatment (PC); B) 
experiencing an adverse reaction to treatment (AR); and C) being inconvenienced by 
participating in treatment (IN). 
 Selles, Rowa, McCabe, Purdon, and Storch (2013) examined the extent, nature, clinical 
correlates and relation to post-treatment outcomes, of treatment concerns in a small sample of 27 
youth with primary OCD. Using a slightly modified version of the TAQ designed specifically for 
youth with OCD (TAQ-C), results of the study indicated that while on average treatment 
concerns were not highly endorsed (the item average was between “slightly disagree” and 
“neither agree or disagree”), identification with concerns was highly variable across the sample. 
In addition, Selles et al. (2013) noted that increased treatment concerns were related to anxiety 
severity, OCD severity, and family accommodation, although not to treatment outcomes.  
 Wu et al. (2015) examined treatment concerns in 119 youth with non-OCD anxiety using 
a slightly modified version of the TAQ intended for this population. Similar to Selles et al. 
(2013), the study found positive correlations between treatment concerns and child-rated anxiety, 
depressive symptoms, and impairment; however, treatment concerns were not associated with 
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parent-rated impairment or clinician-rated anxiety, suggesting concerns may be largely tied to 
individual symptom perceptions. In addition, they study found that treatment concerns mediated 
the relationship between child anxiety and functional impairment. The authors suggest that in the 
face of increasing symptoms, the need for treatment clashes with the child’s fears about 
treatment, leading to increased impairment or perceptions of impairment. 
 
Present Study  
 While the previously mentioned studies have begun to shed light on an understudied area, 
further information regarding the content, extent and clinical correlates of worries anxious 
individuals have regarding beginning behavioral treatment is needed. The TAQ and TAQ-C have 
been helpful in developing this area of research; however, their wording and content is not suited 
to the examination of treatment worries among youth with any anxiety disorder. Accordingly, 
using the TAQ and TAQ-C as starting points, this study sought to examine a newly developed 
measure of youth- and parent-reported worries regarding beginning therapy, namely the 
Treatment Worries Questionnaire (TWQ). With this in mind, the following aims were set for the 
study.  
Specific Aim 1. To examine the nature and extent of treatment concerns as reported by 
children and their primary caregivers. Based on previous research, it was hypothesized that 
overall treatment worries would be present at mild levels, as indicated by an overall mean item 
score falling between 1.0 and 2.5.   
Specific Aim 2. To examine the factor structure of the TWQ-C and the TWQ-P using 
exploratory factor analysis (EFA). Based on the results of Rowa et al. (2014) it was hypothesized 
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that the TWQ-C and TWQ-P would identify 3 highly correlated factors (i.e. PC, AR, IN) with 
good factor loadings and strong internal consistency among factors.  
Specific Aim 3. To examine the reliability of the TWQ-C and TWQ-P, specifically the 
measures’ internal consistency and one-week test-retest reliability. It was hypothesized that both 
the TWQ-C and TWQ-P would have good to excellent internal consistency and test-retest 
reliability.  
Specific Aim 4. To examine the validity of the TWQ-C and TWQ-P, specifically the 
measures’ convergent validity and divergent validity. It was hypothesized that the TWQ-C and 
TWQ-P would demonstrate good convergent validity as evidenced by moderate correlations with 
child- and parent-reported anxiety severity and treatment expectancy. Similarly, it was 
hypothesized that the TWQ-C and TWQ-P would demonstrate good divergent validity as 
evidenced by weak correlations with externalizing symptoms, social desirability, and frequency 
of physical exercise. 
Exploratory Aim 1. To explore the relationship of additional clinical characteristics to the 
nature and extent of treatment concerns reported by parents and children. Based on previous 
research it was hypothesized that treatment concerns would be related to the extent of family 
accommodation, anxiety sensitivity, parental anxiety, and patient insight. 
Exploratory Aim 2. To explore the correspondence on paired items between child and 
parent report. It was hypothesized that ratings of paired items on the TWQ-C and TWQ-P would 
be highly correlated. 
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Methods  
 
Participants  
 Participants were 94 child-parent dyads seeking treatment for anxiety at one of two 
evaluation and treatment clinics for anxiety and obsessive-compulsive and related disorders, 
namely: A) the Rothman Center for Neuropsychiatry, associated with the University of South 
Florida, Departments of Pediatrics (n = 51); or B) the Child and Adolescent Anxiety Disorders 
Program at the Mayo Clinic (n = 43). Recruitment took place following the dyads’ initial clinic 
visit (i.e., a clinical evaluation with a licensed psychologist or a research assessment for an 
anxiety-focused treatment trial). Participants were considered eligible for the study if the 
following inclusion criteria were met: a) scored >10 on the Pediatric Anxiety Rating Scale 5-item 
total (RUPP, 2002); b) were between the ages of 7 – 17 years; c) were considering behavioral 
treatment; d) had a parent or legal primary caregiver willing to participate in study procedures; 
and e) were fluent in English. Participants will be excluded from the study if they: a) were 
actively suicidal; b) exhibited symptoms of mania or psychosis; c) lacked 
reading/comprehension skills sufficient to complete the study; d) had received multiple sessions 
of CBT immediately prior to coming in for treatment; and e) were unwilling to complete the 
study procedures.  
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Measures 
 Demographic Form (DEMO; Appendix A). The DEMO form consisted of 12 items to 
obtain basic demographic information from families regarding the parent (i.e., caregiver type, 
age, household income), the child (i.e., age, gender, ethnicity, living situation), schooling (i.e. 
school type, grade), and treatment (i.e. psychotherapy history, current medication status).   
 Treatment Worries Questionnaire – Initial Child (TWQ-C; Appendix B) and Parent 
Versions (TWQ-P; Appendix C). The TWQ-C and TWQ-P are self developed measures that 
obtain a child and parent self-report of worries regarding beginning behavioral treatment. The 
TWQ-C and TWQ-P are comprised of 20 and 26 items respectively rated on a 6-point likert-type 
scale, with scores ranging from 0 (not worried) to 5 (very worried). Given that treatment worries 
may be similar between youth and their parent(s), as well as diverse, the TWQ-C and TWQ-P 
consist of 15 matched items, while the TWQ-C has an additional five child specific items and the 
TWQ-P has an additional 11 parent specific items.  
 Initially the TWQ was developed as a modified version of an existing adult self-report 
questionnaire, named the Treatment Ambivalence Questionnaire (TAQ; Purdon, Rowa, Gifford, 
McCabe, & Antony, 2012). In order to develop the measure into child and parent reports, items 
were reworded. In addition, the measures’ scale was altered from 1 (strongly disagree) to 7 
(strongly agree) to 0 (not worried) – 5 (very worried). Considering that parents and children are 
asked to rate how much they worry about the listed items, eliminating the “disagreement” 
portion of the scale appeared appropriate. Further, this modification simplified the scale for use 
in children (i.e., reduces the number of options, eliminates neutral option) and better mirrors 
scale formats typically used on child self-report forms (e.g., SCAS). This initial draft of the scale 
was circulated among a group of expert child psychologists familiar with youth with anxiety 
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disorders. Experts were asked to informally comment on the appropriateness, relevance, 
readability, and clarity of items, as well as the comprehensiveness of the measure. Based on 
responses, item wordings were further revised, a number of items from the TAQ were deemed 
non-relevant and were removed, and a number of new items were created and added based on 
suggestions.  
 Following informal examination, the Delphi Method was employed to obtain expert 
consensus on the content and design of the measure. In cases when the nature of the outcome of 
interest, in this case worries regarding beginning treatment, is unknown, the Delphi Method is 
recommended to establish clinical consensus regarding likely content (Adler & Ziglio, 1996). A 
panel of 7 individuals was created that included licensed psychologists and post-doctoral 
clinicians from the University of South Florida who were experienced with cognitive-behavioral 
treatment, anxiety disorders, and measurement/test development. In the first round, panelists 
were asked to comment on the content, format (i.e., length, scale type), language (i.e., 
readability, comparability), and suitable population of the measure. Based on the result of the 
first round the scale’s questions, wording and focus was further refined, while the 4-item likert 
scale was retained.  
 The panelists were sent the measures for a second round, in which they were asked to 
comment on the revised content and language. Feedback from the second round indicated that 
most individuals felt the measure was improved and only minimal suggestions for changes in 
content and language were made. These changes were addressed and the measure was finalized.   
 Spence Child Anxiety Scale – Child and Parent Versions (SCAS; Spence, 1998 and 
SCAS-P; Nauta et al., 2004). Comprised of 38 items, the SCAS and SCAS-P were employed to 
measure the type, and frequency of occurrence, of youth’s anxiety symptoms. Items are scored 
 14 
on a 4-point likert-type scale ranging from 0 (never) to 3 (always) and assess symptoms in six 
domains of anxiety, namely: panic/agoraphobia, social phobia, separation anxiety, generalized 
anxiety, obsessions/compulsions, and fear of physical injury. Psychometric properties of the 
SCAS and SCAS-P are well established with high internal consistency for subscale and total 
scores, acceptable test-retest reliability, and strong convergent and divergent validity (Nauta et 
al., 2004; Spence, 1998).  
 Pediatric Anxiety Rating Scale (PARS; RUPP, 2002). The PARS is a clinician rated scale 
that assesses both child and parent reports of child anxiety frequency, intensity, avoidance, and 
impairment over the past week. Psychometric properties for the PARS include good inter-rater 
reliability, test-retest reliability, as well as convergent and divergent validity (RUPP, 2002; 
Storch et al., 2012). The PARS symptom checklist and corresponding items (i.e., total number of 
symptoms, number of physical symptoms) were excluded due to the use of other measures (e.g., 
SCAS, ASIC) that examine similar content in greater detail.  
 Clinical Global Impression – Severity (CGI-Severity; National Institute of Mental Health, 
1985). The CGI-Severity is a single item rating of the severity of general psychopathology as 
judged by the clinician, ranging from 0 (indicating no illness) to 6 (indicating extreme severity). 
Psychometric properties for the CGI-Severity have been well established, including good 
convergent validity and sensitivity to treatment (Storch, Geffken, Merlo, Mann, et al., 2007; 
Storch, Lewin, De Nadai, & Murphy, 2010; Zaider, Heimberg, Fresco, Schneier, & Liebowitz, 
2003). 
 Child Sheehan Disability Scale – Child and Parent Versions (Child (CSDS and CSDS-P; 
Whiteside, 2009). The CSDS is a brief self-report measure that assesses the extent of impairment 
in social, academic, and family functioning that youth experience as a result of their anxiety 
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symptoms. The CSDS-P similarly inquires about the impairment youth experience as a result of 
their anxiety symptoms, but also contains an additional 3 items assessing the extent to which 
parents’ own work, social and family functioning is impaired as a result of their child’s 
symptoms. Both the CSDS and CSDS-P have demonstrated strong psychometric properties 
including internal consistency, test-retest reliability and construct validity (Whiteside, 2009).  
 Anxiety Sensitivity Index for Children (ASIC; Laurent, Schmidt, Catanzaro, Joiner, & 
Kelley, 1998). The ASIC is a 12-item self-report questionnaire that inquires about youth’s 
aversion to their anxiety symptoms. Psychometric properties of the ASIC have been established, 
with results suggesting unique clinical utility, good construct validity, and internal consistency 
(Deacon, Valentiner, Gutierrez, & Blacker, 2002; Laurent et al., 1998). 
 Depression, Anxiety, and Stress Scale – Short Form (DASS-21; Antony, Bieling, Cox, 
Enns, & Swinson, 1998). Measuring depression, anxiety and stress symptoms in adults, the 
DASS-21 is a short form of the 42-item DASS (Lovibond & Lovibond, 1995). Containing 7-
items from each subscale, for a total of 21-items, the DASS-21 has excellent psychometric 
properties, including excellent internal consistency, convergent validity, as well as a clean factor 
structure and is comparable to the full DASS (Antony et al., 1998; Lovibond & Lovibond, 1995). 
 Iowa Conners Rating Scale (ICRS; Loney & Milich, 1982). The ICRS is a widely used 
brief measure of inattentive, impulsive and overactive symptoms in children, as well as 
oppositional-defiant behavior. The measure consists of 10 parent-reported items focused on the 
frequency of these symptoms in children. Psychometric properties of the ICRS include good 
internal consistency, test-retest reliability and construct validity (Waschbusch & Willoughby, 
2008).  
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 Measure of Insight (Appendix F). Derived from the well-established Children’s Yale-
Brown Obsessive-Compulsive Scale (CY-BOCS; Scahill et al., 1997) question 11, the measure 
of insight consists of a number of verbal prompts appropriate to both OCD and anxiety disorders 
and a single-clinician rated item with anchored scores ranging from 0 (excellent insight) to 4 
(lacks insight). Previous studies examining insight in OCD have used the CY-BOCS question 11 
as the primary measure of insight (Lewin et al., 2010; Storch, Milsom, et al., 2008) and it has 
demonstrated excellent inter-rater reliability (Lewin et al., 2010).  
 Family Accommodation Scale – Anxiety (FASA; Lebowitz et al., 2013). Comprised of 9-
parent rated items, the FASA assesses the degree to which family members accommodated the 
child’s anxiety symptoms, either through active participation (e.g., provision of reassurance; 
assistance in avoidance) or modification of functioning (e.g., change to family, work or leisure 
routines; fulfillment of child’s responsibilities). Internal consistency, as well as convergent and 
divergent validity for the FASA are good (Lebowitz et al., 2013). 
 Child Avoidance Measure (CAM; Whiteside, Gryczkowski, Ale, Brown-Jacobsen, & 
McCarthy, 2013). With both child self-report and parent versions, the CAM consists of eight 
items that assess children’s behavioral avoidance of feared stimuli. Both scales have shown 
internal consistency and convergent validity (Whiteside et al., 2013).  
 Expectancy Rating Questionnaire (ERQ; Borkovec & Nau, 1972). The ERQ has been 
used in various forms to measure of treatment expectancy and rationale credibility. Psychometric 
examination suggests the ERQ has a stable factor structure and good reliability including internal 
consistency and test-retest reliability (Devilly & Borkovec, 2000). Both parents and children 
completed the ERQ.  
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 Marlowe-Crowne Social Desirability Scale – Form X1 (SDS; Strahan & Gerbasi, 1972). 
The SDS-X1 is a 10-item abbreviated version of the Marlowe-Crowne Social Desirability Scale 
(Crowne & Marlowe, 1960). This self-report form evaluates the extent to which individuals 
attempt to present themselves in a socially desirable light using true-false statements. The 
employed abbreviated version is considered the best version of the SDS due to its good 
psychometric properties and relationship to the latent construct (Fischer & Fick, 1993).  
 Measure of Moderate to Vigorous Physical Activity (MVPA; Prochaska, Sallis, & Long, 
2001). The MVPA is a self-report measure of the frequency in which youth complete moderate 
to vigorous physical activity (i.e. increases heart rate and shortness of breath) for at least 60 
minutes per day over the past 7 days, as well as over a typical or usual week. The MVPA has 
been established as reliable and valid and is recommended for clinical practice (Prochaska et al., 
2001). 
Table 1. Measures and Corresponding Respondents. 
 
 
 
Procedure 
 All research procedures were reviewed and approved by the institutional review boards of 
both the University of the South Florida (see appendix A) and the Mayo Clinic (see appendix B). 
Following completion of an initial clinic visit at the Rothman Center for Neuropsychiatry or the 
Measure Child Parent Clinician 
Demo  X  
TWQ X X  
SCAS X X  
PARS   X 
CGI-Severity   X 
CSDS X X  
ASIC X   
DASS-21  X  
ICRS  X  
Measure of Insight   X 
FASA  X  
CAM X X  
ERQ X X  
SDS X X  
MVPA X   
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Mayo Clinic that was used to establish general presenting problems and eligibility, potential 
participants were introduced to study personnel by their intake clinician. Youth and their primary 
caregiver were informed regarding the nature and requirements of the present study and were 
asked whether they would be interested in participating. Given time constraints on the day of 
their initial appointment, some families opted to return for the study prior to their first therapy 
session. Interested families were walked through the informed consent, which explained in detail 
the nature of the project, as well as any perceived risks or benefits. As part of the informed 
consent, families agreed to, or opted out of, participation in a retest of the TWQ-C and TWQ-P 
approximately 1-week following their initial administration (so long as this was prior to their 
initiation of treatment). If, at the end of the consent, both the child and parent were willing to 
participate, written assent from youth, written consent from the parent or legal guardian for the 
child’s participation, and written consent from the parent or legal guardian regarding their own 
participation, was obtained. To ensure consistent information was provided to families across 
sites, parents and children were provided with a brief description of cognitive behavioral therapy 
for anxiety/OCD which they read before completing the questionnaires (see Appendix G). The 
packets of child and parent report measures were then administered, following which study 
personnel completed the three clinician-rated measures. Families that agreed and were able to 
complete the retest portion (i.e., had not yet had their first therapy session), completed the TWQ-
C and TWQ-P in person prior to their initial therapy session, approximately 1-week following 
their initial assessment. Following completion of the study, clinical diagnoses were determined 
using best estimate procedures (Leckman, Sholomskas, Thompson, Belanger, & Weissman, 
1982) drawing information from the youth’s initial evaluation (i.e., clinical interview with a 
licensed psychologist or structured research assessment), subscale scores on the SCAS and 
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SCAS-P, and any available medical records. Data from the measures were then entered into 
SPSS, and stored in files located on password-protected drives only accessible to study 
personnel.  
 
Design Considerations 
 Measure Focus. The focus and content of the TWQ was carefully considered during 
development of the present study. First, it was considered whether the TWQ-C and TWQ-P 
should function as equivalent or individual measures. Under an equivalent format, the TWQ-P 
would function as a paired parent report to the TWQ-C of the child’s treatment concerns. While 
this format would allow for examination of inter-rater reliability and would capture parents’ 
perceptions of their child’s worries, it would not capture parents’ personal identification with 
treatment worries. The alternative option, which was ultimately selected, framed the measures as 
two self-report questionnaires, one measuring the parent’s treatment worries and the other the 
child’s. This format allows unique concerns that children or parents may have to be included on 
each scale and captures the parent’s level of worry regarding treatment, rather than just the 
child’s. Despite this model, it was theorized that while some concerns may be unique to parents 
or children, many concerns would be similarly applicable. Therefore, 15 of the items on the 
TWQ were matched.  
 An additional consideration of the measure’s focus was its breadth (i.e., whether it should 
be applicable across disorders and treatment approaches). While it is discussed earlier that youth 
seeking CBT for anxiety and their parents may be particularly concerned about treatment 
beginning, applying a broad framework to the measure allows investigation of treatment 
concerns amongst youth with other disorders seeking other forms of treatment. While this may 
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limit unique information specific to CBT for anxiety (e.g., fear regarding exposures), we 
determined that a broader form of the measure was still capable of providing detailed 
information regarding what aspects of treatment may be particularly concerning for youth or 
their parents. This broader format provides a more generalizable measure and allows for future 
studies to examine treatment worries in a wide variety of populations.  
 Participant Age. The age range for youth participating in the study was selected based on 
a number of factors. If young children were not able to understand the measure, their inclusion 
would risk the addition of unwanted error variance into the overall data; however,  including 
younger-aged youth widened the potential participant pool, increases the generalizability of the 
measure, and better reflects the early age of onset of many anxiety disorders. Feedback from 
experts during the first round of the Delphi examination varied, with suggestions of a lowest age 
ranging from 7-years old to 12-years old. Refinements to the measure’s language were made to 
increase readability for children, and analysis of the TWQ-C’s reading level indicates a Flesh-
Kincaid grade equivalent of 5.0. Taking this into account, as well as the inclusion of a study 
criteria that excluded youth who were not appear able to read/comprehend study measures, 7-
years old was selected as the lowest age for the study.  
 Feasibility. While collecting a large array of information regarding participants was of 
interest, keeping the assessment packet as brief and easy to complete as possible was believed to 
make the study more attractive to potential participants and reduce the burden on study 
personnel. Therefore a number of decisions regarding the study’s composition were made. First, 
wherever possible, child and parent report measures were selected over clinician report 
measures, in order to limit the time necessary from study personnel and allow families more 
flexibility in completing the measures. Second, it was decided that the study would not include a 
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full structured diagnostic interview, in favor of a continuous anxiety score cut-off for inclusion 
criteria and the use of best estimate procedures to establish specific diagnoses (Leckman et al., 
1982). Considering all included patients completed an initial intake interview or structured 
research assessment, full structured diagnostic interviews was considered to be redundant and 
highly burdensome on both participants and study personnel. Additionally, the use of a non-
disorder specific, continuous measure of anxiety severity (i.e., PARS; CGI-Severity) better 
reflects a dimensional conceptualization of anxiety, an approach to measurement encouraged by 
the National Institute of Mental Health’s Research Domain Criteria (RDoC) initiative. Not 
burdened by problems of comorbidity, the RDoC approach is advantageous as it acknowledges 
the similar mechanisms that underlie the symptoms and treatment of anxiety disorders (Sanislow 
et al., 2010). Finally, drawing information from the initial intake interview, the patient’s history, 
and sub-scale scores on the SCAS and SCAS-P, the use of best estimate procedures to establish 
diagnoses is empirically supported (Leckman et al., 1982) and better mirrors clinical practice 
than the use of full structured diagnostic interviews.  
 Sample Size. Power analysis and calculation of sample size for the present study were 
driven primarily by considerations for the factor analysis and data collection feasibility. Multiple 
guidelines for sample size within EFA have been made (e.g., 10 participants per item); however, 
significant variation exists between different guidelines, and strict adherence to guidelines fails 
to account for characteristics of the measure, sample and/or data that may impact power 
(Fabrigar, Wegener, MacCallum, & Strahan, 1999). In particular, in samples where factors are 
overdetermined (i.e., at least three items load onto each factor) and share a high level of 
communality, accurate factor estimates can be obtained with samples of approximately 100 
participants (MacCallum, Widaman, Zhang, & Hong, 1999). While one cannot be certain 
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whether a sample will have these characteristics until after data collection, reasonable hypotheses 
can be made. For the present study, the ratio of items to hypothesized factors (i.e., >4) suggested 
that the factors identified will be overidentified. Additionally, the extensive development of the 
two measures’ item content to produce measures examining an overall construct, lended support 
to the measures factor’s likely sharing variance. Therefore, the final obtained sample of 
completed TWQs from 94 youth and 92 parents was considered sufficient to examine the data. 
 
Data Management   
Parent-child dyads in the study were assigned a participant ID. Any identifiable 
information was stored in a separate locked cabinet from de-identified data. Data collected as 
part of the study procedures was entered in an ongoing fashion into the Statistical Package for 
Social Sciences (SPSS) software. Databases were stored on a secure drive at the Rothman Center 
for Pediatric Neuropsychiatry. Throughout the study, completeness of data was carefully 
monitored.  
If participants had greater than 10% missing on any measure, they were excluded from 
the analyses for that measure, but were retained for analyses on other measures (provided they 
had less than 10% of data missing). Minimal missing data was identified for the TWQ-C (one 
item missing: n = 4) and TWQ-P (one item missing: n = 2; three items missing: n = 3; not 
completed: n = 2). Mean imputation was used as no theoretically relevant deck variables were 
identified. Mean imputation was also used for the Social Desirability Scale for similar reasons. 
For the SCAS, SCAS-P, CASI, and FASA, data were imputed through hot deck procedures 
outlined by Myers (2011) with CGI-Severity score and child gender serving as deck variables. If 
individuals were also missing CGI-S data, mean imputation was used in place of hot deck 
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procedures. For the SCAS and SCAS-P, subscale means were used. Finally, missing data for the 
DASS were imputed using hot deck procedures with CGI-S score and parent gender serving as 
deck variables.   
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Results 
 
Sample Characteristics 
 The final sample was comprised of 94 child-parent dyads. The sample was largely 
Caucasian (89%; n = 84), with 62% female youth (n = 58) and 88% female parents (n = 79; 
missing parent gender: n = 4). Child age ranged from 7-17 with an average patient age of 12.31 
years (SD = 2.83). Both prior psychosocial treatment and current medications were common. 
OCD was the most common diagnosis occurring in 42% of the sample (n = 39), followed by 
‘other anxiety disorder’ (e.g., anxiety disorder -  not otherwise specified, panic disorder, 
adjustment disorder with anxiety; n =  15), GAD (n = 14), social phobia (n = 14), specific phobia 
(n = 7), and separation anxiety (n = 5). Full sample characteristics are presented in Table 2. 
 
Treatment Worries Questionnaire – Child Version 
 Specific Aim 1. Evaluation of the nature and extent of treatment worries endorsed by 
children was completed by examining averages and standard deviations of the TWQ-C items and 
total scores. Based on the measures’ scale, the following guide for item averages was used: A) no 
concerns: M < 1; B) mild: 1.0 < M > 2.5; B) moderate: 2.5 < M > 4.0; and C) high: M > 4.0. 
Table 3 displays the means, standard deviations, and percentage of children who 
endorsed the highest two item scores for all items of the TWQ-C. For children, three items had 
the highest item averages and the highest frequency of top response option endorsement.   
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Table 2. Sample Characteristics  
Parent N (%) 
 Gender  
 Female 79 (84) 
Male 11 (12) 
Missing  4 (4) 
Education  
 High School/GED 11 (12) 
Associates/Trade  19 (20) 
Bachelor’s Degree 34 (36) 
Graduate Degree 27 (29) 
Missing 3 (3) 
Child M (SD)/ N (%) 
 
Age 12.31 (2.83) 
Female 58 (62) 
Race/Ethnicity  
 Caucasian 84 (89) 
Hispanic/Latin American 6 (6) 
Asian 1 (1) 
Mixed Race/Other 1 (1) 
Missing 1 (1) 
Prior Psychosocial Treatment  
 Yes 56 (60) 
No 36 (38) 
Missing 2 (2) 
Current Medication  
 Yes 44 (47) 
No 43 (46) 
Missing 7 (7) 
Primary Diagnosis  
 Obsessive Compulsive 39 (42) 
Generalized Anxiety 14 (15) 
Social Phobia 14 (15) 
Separation Anxiety 5 (5) 
Specific Phobia 8 (9) 
Panic Disorder 1 (1) 
Anxiety NOS 11 (12) 
Adjustment Disorder with Anxiety 2 (2) 
 
Table 3. Individual Item Outcomes of the TWQ-C 
 Item content M SD Top 2 (%) 
1  …therapy is going to make me miss too much school or other important activities outside of school (clubs, 
sports, lessons, etc). 1.41 1.51 11 
2  …if I don’t get better, I’ll feel more frustrated, upset, or embarrassed about my problems than I do now.  2.13 1.69 28 
3  …therapy will be too hard. 1.55 1.58 16 
4  …if I go for therapy, people might think my problems are bigger than they really are. 1.49 1.75 19 
5  …therapy won’t help me. 1.49 1.68 19 
6  …my therapist won’t understand me or my problems. 1.06 1.42 10 
7  …if people find out I’m in therapy, it could be bad for my life (get teased, ruin my future). 1.22 1.45 12 
8  …therapy will be really upsetting.                                                              1.49 1.71 17 
9  …therapy will make me have new problems.                                         0.92 1.42 10 
10  …starting therapy means that there is really something wrong with me. 1.17 1.47 11 
11  …therapy will make me change in ways I won’t like.  0.89 1.37 11 
12  …even if therapy helps, my problems will just come back. 1.64 1.55 12 
13  …if I don’t get better during therapy, my problems will never go away.  1.87 1.75 22 
14  …going for therapy will make me feel embarrassed. 1.31 1.56 13 
15  …therapy will make my problems worse.                                                        0.71 1.29 6 
16  …therapy is going to take up time I could spend doing things I like. 1.53 1.71 17 
17  …I will have to talk about things I don’t want to talk about. 2.30 1.82 32 
18  …therapy will make me change things I don’t want to change. 1.16 1.59 15 
19  …therapy will make me change how I deal with my problems and I’ll lose control.  1.04 1.57 13 
20  …if I don’t get better during therapy, my parent(s) will be disappointed in me.  1.35 1.71 15 
 
 26 
These items were: 1) item 17 (“I will have to talk about things I don’t want to talk about”: M = 
2.30; SD = 1.82; Top 2 = 32%); 2) item 2 (“if I don’t get better, I’ll feel more frustrated, upset, or 
embarrassed about my problems than I do now”: M = 2.13; SD = 1.69; Top 2 = 28%); 3) item 13 
(“if I don’t get better during therapy, my problems will never go away”: M = 1.87; SD = 1.75; 
Top 2 = 22%). The fourth and fifth highest average rated items were item 12 (“even if therapy 
helps, my problems will just come back”: M = 1.64; SD = 1.55; Top 2 = 12%); and 5) and item 3 
(“therapy will be too hard”: M = 1.55; SD = 1.58; Top 2 = 16%), while the fourth and fifth 
mostly like items to receive the highest response options were item 5 (“therapy won’t help me”: 
M = 1.49; SD = 1.68; Top 2 = 19%); and item 4 (“if I go for therapy, people might think my 
problems are bigger than they really are”: M = 1.49; SD = 1.75; Top 2 = 19%).  
Three items were infrequently endorsed by youth and demonstrated significant item 
skewness, specifically items 9 (“therapy will make me have new problems”: M = 0.92; SD = 
1.42), 11 (“therapy will make me change in ways I won’t like”: M = 0.89; SD = 1.37), and 15 
(“therapy will make my problems worse”: M = 0.71; SD = 1.29). These three items similarly 
inquire, unlike any other items on the scale, about worries that therapy will produce a negative 
change in the person and/or their symptoms. Given the shared non-endorsement of this domain 
as indicated by the low overall frequency with which individuals endorsed these items, it was 
determined that these items should be removed from the scale.  
 Using the revised 17-item scale (see Appendix E), overall, treatment worries were 
endorsed at mild levels by children with an item average of 1.48 (Range: 0 – 70; M = 25.21, SD 
= 18.33). Regarding response profiles, similarly large portions of youth reported few concerns 
(38%; n = 36) or mild levels of concern (42%; n = 39). A small portion of the sample reported 
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moderate levels of concern (19%; n = 18), while only one youth consistently reported high levels 
of concern (1%; n = 1).  
Specific Aim 2. Examination of the factor structure of the TWQ-C was completed using a 
common factor analysis, under a promax oblique rotation (recommended when factors may be 
interrelated). The eigenvalue method, examination of scree plots, and parallel analysis was used 
to determine the number of factors. Consistent with development of the TAQ (Rowa et al., 
2014), items were required to have a minimum factor loading of .32 (Tabachnick & Fidell, 2001) 
and items were considered double loaded if values were within .10 of each other. To confirm 
removal of items 9, 11, and 15, the factor analysis was completed with and without their 
inclusion. When included, the TWQ-C demonstrated less well defined factors and these items 
exhibited low factor loadings, supporting their removal. Therefore, all following analyses and 
results are for the 17-item scale.  
Eigenvalues, the scree plot, and parallel analysis generally supported the hypothesized 
three-factor structure (1-Factor: 7.27; 2-Factor: 1.12; 3-Factor: 0.97; 4-Factor: 0.36; See Figure 
1). Upon item examination, the three factor model produced unique factors (see Table 4). The 
factors related to: A) Difficulty: worry about difficulties and inconveniences associated with 
engaging in therapy (8 items); B) Failure: worry about treatment failing and associated 
consequences (4 items) and C) Stigma: worry about perceptions or stigma-related consequences 
to engaging in treatment (5 items). Item 5 (i.e., I worry that treatment won’t help me) loaded 
moderately onto the Difficulty factor in addition to a strong loading on the Failure factor; 
however, the loading difference was greater than .10 so the item was retained on the Failure 
factor. All factors were significantly correlated: Difficulty and Failure: (r = .61, p < .001); 
Difficulty and Stigma: (r = .66, p < .001); and Failure and Stigma (r = .55: p < .001). Factor item 
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means were highest for worries related to Failure (M = 1.78), followed by Difficulty (M = 1.44), 
and Stigma (M = 1.31). 
Figure 1. Scree Plots of Eigenvalues for the TWQ-C and Parallel Analysis 
 
 
Table 4. Factor Structure of the TWQ-C 
 Item content Difficulty Failure Stigma 
1 …therapy is going to make me miss too much school or other important activities outside of 
school (clubs, sports, lessons, etc). .429 -.122 .250 
2 …if I don’t get better, I’ll feel more frustrated, upset, or embarrassed about my problems 
than I do now.  -.083 .560 .160 
3 …therapy will be too hard. .689 .090 -.038 
4 …if I go for therapy, people might think my problems are bigger than they really are. .067 .050 .714 
5 …therapy won’t help me. .461 .571 -.224 
6 …my therapist won’t understand me or my problems. .583 .304 -.086 
7 …if people find out I’m in therapy, it could be bad for my life (get teased, ruin my future). -.032         .026          .777 
8 …therapy will be really upsetting.                                                              .741 .229 -.054 
10 …starting therapy means that there is really something wrong with me. .074 .058 .728 
12 …even if therapy helps, my problems will just come back. .167 .723 .094 
13 …if I don’t get better during therapy, my problems will never go away.  -.028 .672 .209 
14 …going for therapy will make me feel embarrassed. -.005 .039 .805 
16  …therapy is going to take up time I could spend doing things I like. .607 -.313 .095 
17  …I will have to talk about things I don’t want to talk about. .494 .084 .213 
18  …therapy will make me change things I don’t want to change. .647 .201 .037 
19  …therapy will make me change how I deal with my problems and I’ll lose control.  .496 .201 .217 
20  …if I don’t get better during therapy, my parent(s) will be disappointed in me.  .292 .101 .430 
 
Specific Aim 3. Evaluation of the reliability of the TWQ-C focused on the internal 
consistency and test-retest reliability of the measure. Internal consistency of the measure was 
evaluated using Cronbach’s alpha (Cronbach, 1951). As hypothesized, the TWQ-C demonstrated 
excellent internal consistency in children (a = .92). Internal consistency of each factor was in the 
good range (Difficulty: a = .87; Failure: a = .87; and Stigma: a = .87). For the subsample of 
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youth that completed the TWQ-C twice (n = 14), Pearson correlation coefficients were used to 
compare the measure’s total score between time-points. Test-retest reliability was excellent for 
total score (r = .92, p < .001) and in the good range for Difficulty (r = .88, p < .001), Failure (r = 
.89, p < .001), and Stigma (r = .86, p < .001). 
Specific Aim 4. Evaluation of the validity of the TWQ-C focused on the convergent 
validity and divergent validity. Convergent validity was assessed by examining Pearson 
correlation coefficients between the measure and child-reports of anxiety severity, impairment, 
and treatment expectancy, as well as clinician-rated anxiety severity/impairment. The TWQ-C 
demonstrated good convergent validity, as evidenced by moderate positive correlations with 
child-rated levels of anxiety severity as measured by the SCAS (r = .42, p < .001) and treatment 
expectancy as measured by the TEQ-C (r = -.58, p < .001). Of SCAS subscales, social anxiety (r 
= .47, p < .001), panic symptoms (r = .38, p = .001), and generalized anxiety (r = .37, p = .001) 
were significantly correlated with TWQ-C total scores. These relationships were consistent 
across factors (see Table 5), although in general the Failure factor showed the strongest 
relationships with self-reported anxiety while the Difficulty factor demonstrated the weakest. 
Overall treatment worries were not significantly related to child-rated anxiety-related impairment 
(r = .20, p = .06). Clinician-rated anxiety severity/impairment (r = .11, p = .31) was also not 
associated with child-rated treatment worries.  
Table 5. Convergent Validity of the TWQ-C  
 Child-Rated Anxiety Symptoms Anxiety 
Impairment 
Treatment 
Expectancy 
Clinician-
Rated Anxiety  Total Separation Social OCD Panic Injury GAD 
Total .42** .09 .47** .17 .38** .19 .37** .20 -.58** .11 
Difficulty .30** .08 .33** .11 .27* .20 .24* .17 -.59** .10 
Failure .45** .14 .48** .18 .39** .10 .48** .23* -.48** .07 
Stigma .38** .01 .47** .18 .36** .17 .31** .21* -.39** .12 
* p < .05; ** p < .001 
 
Divergent validity was assessed by examining Pearson correlation coefficients between 
the TWQ-C and scales of externalizing symptoms, social desirability ratings, and frequency of 
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physical exercise (see Table 6). The TWQ-C exhibited weak to small (all non-significant) 
correlations with child ratings of physical exercise (r = -.17, p = .10), child ratings of social 
desirability (r = -.11, p = .30) and parent-rated externalizing symptoms (r = .04, p = .72). 
Table 6. Divergent Validity of the TWQ-C  
 Social 
Desirability 
Externalizing Symptoms Exercise Total ADHD ODD 
Total -.13 .04 -.11 .05 -.17 
Difficulty -.15 .04 -.16 .05 -.13 
Failure -.09 -.01 -.01 -.01 -.21* 
Stigma -.13 .06 -.07 .09 -.13 
* p < .05; ** p < .001 
 
Exploratory Aim 1. Exploration of variables that may influence the nature and extent of 
treatment concerns was completed using t-tests and Pearson correlation coefficients. In 
particular, TWQ-C scores were examined for their relationship to child age, gender, past 
psychosocial treatment, current medication status, anxiety sensitivity, patient insight, avoidance, 
and extent of family accommodation. Treatment worries did not differ significantly between 
males and females (t (92) = .68, p = .50), but did show a small positive association with age (r = 
.23, p = .02), which appeared to be driven by responses on the Failure factor (r = .31, p = .003). 
Past psychotherapy was not associated with child worries (t (92) = -.85, p = .39), nor was 
medication status (t (92) = -1.11, p = .27). Child ratings of anxiety sensitivity were highly related 
to treatment worries (r = .55, p < .001), while child-rated avoidance, parent-rated family 
accommodation, parent-rated depression, anxiety, and stress, and clinician-rated child insight 
were not significantly associated with treatment worries (see Table 7).  
Table 7. Exploratory Clinical Correlates of the TWQ-C  
 Age Anxiety Sensitivity Avoidance 
Family 
Accommodation Insight 
Parent 
Depression 
Parent 
Anxiety 
Parent 
Stress 
Total .23* .55** .11 .02 -.04 .09 .16 .13 
Difficulty .17 .44** .07 .02 .05 -.06 .08 .07 
Failure .31** .50** .22* -.01 -.17 .15 .14 .17 
Stigma 0.16 .51** .03 .02 -.04 -.02 .23* .11 
* p < .05; ** p < .001 
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Treatment Worries Questionnaire – Parent Version 
 Specific Aim 1. Evaluation of the nature and extent of treatment worries endorsed by 
parents was completed by examining averages and standard deviations of the TWQ-P items and 
total scores. Based on the measures’ scale, the following guide for item averages was used: A) no 
concerns: M < 1; B) mild: 1.0 < M > 2.5; B) moderate: 2.5 < M > 4.0; and C) high: M > 4.0. 
Table 8 displays the means, standard deviations, and percentage of parents endorsing the 
highest two item scores for all items of the TWQ-P. For parents, the five items that had the 
highest item averages and the highest frequency of top response option endorsement (with the 
exclusion of item 12) were: 1) item 2 (“if therapy doesn’t work, my child will feel more 
frustrated, upset, or embarrassed about their symptoms than they already do”: M = 2.24; SD = 
1.42; Top 2 = 22% ); 2) item 13 (“if therapy doesn’t work, my child’s symptoms will never go 
away”: M = 2.02; SD = 1.52; Top 2 = 20%); 3) item 12 (“even if therapy helps, my child’s 
symptoms will return”: M = 1.80; SD = 1.32; Top 2 = 9%); 4) item 23 (“if therapy doesn’t work, 
we will have to try methods of treatment I am not as comfortable with”: M = 1.53; SD = 1.66; 
Top 2 = 17%); and 5) and item 21 (“meeting the logistic demands of therapy will be too 
difficult”: M = 1.55; SD = 1.33; Top 2 = 10%). 
The three items least endorsed on average by parents were: 1) item 25 (“therapy will 
make my child change in ways I won’t like”: M = 0.20; SD = 0.54); 2) item 11 (“therapy will 
change my child in ways he/she won’t like”; M = 0.25; SD = 0.53); and 3) item 10 (“starting my 
child in therapy means admitting there is something wrong with him/her”: M = 0.27; SD = 0.53). 
Item 25 expresses the same theme as the poorly endorsed/removed items from the TWQ-C and 
further supports the removal of this theme from the questionnaires. Therefore, consistent with the 
TWQ-C, items 9, 11, 15, and 25 were removed. Other infrequently endorsed items from the 
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TWQ-P were maintained for examination in alternative samples where it is believe these worries 
may be more relevant (e.g., non-treatment seeking sample).  
Table 8. Individual Item Outcomes of the TWQ-P 
 Item Content M SD Top 2 (%) 
1  …therapy is going to get in the way of my child’s education or extracurricular activities. 0.83 1.25 2 
2  …if therapy doesn’t work, my child will feel more frustrated, upset, or embarrassed about their symptoms 
than they already do. 2.24 1.42 22 
3  …therapy will be too hard for my child. 1.15 1.27 17 
4  …if my child goes for therapy, people might think his/her problems are bigger than they really are. 0.70 1.07 4 
5  …therapy won’t help my child. 1.45 1.50 12 
6  …my child’s therapist won’t understand my child or my child’s symptoms. 0.80 1.17 3 
7  …if people find out my child is in therapy, it could negatively impact my child’s life (e.g., be teased, ruin 
future opportunities). 1.08 1.38 9 
8  …therapy will be upsetting for my child. 1.15 1.33 6 
9  …therapy will somehow result in new symptoms. 0.67 1.03 8 
10  …starting my child in therapy means admitting there is something wrong with him/her. 0.27 0.70 1 
11  …therapy will change my child in ways he/she won’t like. 0.25 0.53 0 
12  …even if therapy helps, my child’s symptoms will return. 1.80 1.32 9 
13  …if therapy doesn’t work, my child’s symptoms will never go away. 2.02 1.52 20 
14  …going for therapy will make my child feel embarrassed. 1.08 1.24 7 
15  …therapy will make my child’s symptoms worse.                                                        0.42 0.92 3 
16  …therapy will be a waste of time and money. 0.44 0.76 0 
17  …my child won’t be honest in therapy. 1.26 1.30 7 
18  …my child’s therapist will think I’m a bad parent. 0.55 1.02 2 
19  …therapy is going to get in the way of my personal responsibilities (e.g., work, family). 0.99 1.21 4 
20  …therapy may put my child’s privacy at risk. 0.60 1.03 2 
21  …meeting the logistic demands of therapy (e.g., scheduling, cost, transportation) will be too difficult. 1.55 1.33 10 
22  …if therapy doesn’t work, I will feel more frustrated, upset, or embarrassed about my child’s symptoms 
than I already do. 1.02 1.26 6 
23  …if therapy doesn’t work, we will have to try methods of treatment I am not as comfortable with 
(medication, hospitalization, etc). 1.53 1.66 17 
24  …my child will not make an effort to improve during therapy. 1.07 1.40 9 
25  …therapy will make my child change in ways I won’t like. 0.20 0.54 0 
26  …therapy will require me to act in ways that will upset my child or make my child think I am mean. 0.74 1.04 2 
 
Using the revised 22-item scale (see Appendix F), overall, treatment worries were 
endorsed at low-mild levels with the item average falling at 1.11 (Range: 0 – 70; M = 24.31, SD 
= 14.72). Regarding total score distribution, the majority of parents reported few concerns (50%; 
n = 46), a large portion endorsed mild concerns (44%; n = 40) and a small portion reported 
moderate concerns (6%; n = 6). 
Specific Aim 2. Examination of the factor structure of the TWQ-P was completed using a 
common factor analysis, under a promax oblique rotation (recommended when factors may be 
interrelated). The eigenvalue method and examination of scree plots was used to determine the 
number of factors. Consistent with development of the TAQ (Rowa et al., 2014), items were 
required to have a minimum factor loading of .32 (Tabachnick & Fidell, 2001) and items were 
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considered double loaded if values were within .10 of each other.  Consistent with the TWQ-C, 
removal of items 9, 11, 15, and 25 was confirmed by completing the factor analysis with and 
without their inclusion. When included, the TWQ-P demonstrated less well defined factors and 
these items exhibited low factor loadings, supporting their removal. Therefore, all following 
analyses and results are for the 22-item scale. 
Eigenvalues, the scree plot, and parallel analysis suggested a four factor model (1-Factor: 
6.18; 2-Factor: 1.69; 3-Factor: 1.51; 4-Factor: 1.17; 5-Factor: 0.70; 6-Factor: 0.65; see Figure 2). 
Upon item examination, the four factor model produced unique and theoretically consistent 
factors (see Table 9). The factors related to: A) Inconvenience: worry about therapy getting in 
the way of life (4 items); B) Adverse Reactions: worry about therapy’s consequences on 
emotional functioning or symptoms (8 items); and C) Stigma: worry about perceptions or 
stigma-related consequences to engaging in treatment (6 items); and D) Therapy Process: worry 
about aspects of the therapy process (4 items). Regarding factor correlations, moderate 
correlations were observed for Adverse Reactions and Stigma (r = .54, p <.001); Adverse 
Reactions and Therapy Process (r = .48, p <.001); and Stigma and Therapy Process (r = .32, p 
<.001). Inconvenience demonstrated small correlations with Adverse Reactions (r = .26, p = .01) 
and Stigma (r = .28, p =.007), but did not demonstrate a relationship with Therapy Process (r = 
.19, p = .06). Factor item means were highest for worries related to Adverse Reactions (M = 
1.55), followed by Inconvenience (M = 0.95), Therapy Process (M = 0.90), and Stigma (M = 
0.76).  
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Figure 2. Scree Plots of Eigenvalues for the TWQ-P and Parallel Analysis  
 
 
Table 9. Factor Structure of the TWQ-P 
 Item Content Inconven Adverse Stigma Process 
1 …therapy is going to get in the way of my child’s education or 
extracurricular activities. .456 .127 .047 .251 
2 …if therapy doesn’t work, my child will feel more frustrated, upset, or 
embarrassed about their symptoms than they already do. -.104 .401 .229 -.026 
3 …therapy will be too hard for my child. -.002 .853 -.179 -.070 
4 …if my child goes for therapy, people might think his/her problems are 
bigger than they really are. .011 .019 .749 .008 
5 …therapy won’t help my child. .139 .462 .105 -.134 
6 …my child’s therapist won’t understand my child or my child’s 
symptoms. -.071 .274 .419 -.159 
7 …if people find out my child is in therapy, it could negatively impact my 
child’s life (e.g., be teased, ruin future opportunities). .153 -.102 .815 -.083 
8 …therapy will be upsetting for my child. -.116 .781 .174 .153 
10 …starting my child in therapy means admitting there is something wrong 
with him/her. -.089 .101 .587 -.056 
12 …even if therapy helps, my child’s symptoms will return. .278 .532 .014 -.084 
13 …if therapy doesn’t work, my child’s symptoms will never go away. .106 .416 .158 -.215 
14 …going for therapy will make my child feel embarrassed. -.094 .217 .650 .135 
16 …therapy will be a waste of time and money. .356 .146 -.079 -.189 
17 …my child won’t be honest in therapy. .037 -.003 .040 -.546 
18 …my child’s therapist will think I’m a bad parent. -.066 -.247 .342 -.669 
19 …therapy is going to get in the way of my personal responsibilities (e.g., 
work, family). .865 .097 -.042 .097 
20 …therapy may put my child’s privacy at risk. .216 -.033 .373 .006 
21  …meeting the logistic demands of therapy (e.g., scheduling, cost, 
transportation) will be too difficult. .623 -.334 .179 -.223 
22  …if therapy doesn’t work, I will feel more frustrated, upset, or 
embarrassed about my child’s symptoms than I already do. -.007 .387 .117 -.239 
23  …if therapy doesn’t work, we will have to try methods of treatment I am 
not as comfortable with (medication, hospitalization, etc). .052 .576 .050 -.002 
24  …my child will not make an effort to improve during therapy. .057 .242 -.285 -.735 
26  …therapy will require me to act in ways that will upset my child or make 
my child think I am mean. -.179 .262 .003 -.615 
 
  
0	1	
2	3	
4	5	
6	7	
One	 Two		Three		Four		 Five		 Six		 Seven		Eight		Nine	 Ten	
Ei
ge
nv
al
ue
	
Number	of	Factors	
TWQP	Parallel	Analysis	
 35 
Specific Aim 3. Evaluation of the reliability of the TWQ-P focused on the internal 
consistency and test-retest reliability of the measures. Internal consistency of the measure was 
evaluated using Cronbach’s alpha (Cronbach, 1951). As hypothesized, the TWQ-P demonstrated 
good internal consistency in parents (a =.88). Internal consistency of each factor varied, falling 
in the good range for the Adverse Reactions (a = .85) and Stigma (a = .80), in the acceptable 
range for the Therapy Process factor (a = .77), and in the questionable range for the  
Inconvenience factor (a = .67). For the subsample of parents that completed the TWQ-P twice (n 
= 14), Pearson correlation coefficients were used to compare the measure’s score between time-
points. For parents, test-retest reliability was in the acceptable range for total score (r = .78, p = 
.001), in the good range for Adverse Reactions (r = .81, p <.001), in the acceptable range for 
Stigma (r = .76, p = .002), and in the questionable range for Inconvenience (r = .61, p = .02) and 
Therapy Process (r = .65, p = .01). 
Specific Aim 4. Evaluation of the validity of the TWQ-P focused on the convergent 
validity and divergent validity. Convergent validity was assessed by examining Pearson 
correlation coefficients between the measure and parent-reports of anxiety severity, impairment, 
treatment expectancy, and clinician rated anxiety severity/impairment (see Table 10). Partially 
confirming hypotheses, the TWQ-P demonstrated convergent validity in some areas, as 
evidenced by a moderate correlation with parent-rated anxiety-related impairment (CSDS-P; r = 
.37, p < .001), but only a small correlation with parent-rated anxiety SCAS-P (r = .27, p = .01). 
Rather than the consistent relationships observed with the TWQ-C, these relationships appeared 
specific to treatment worry factors. Specifically, the Adverse Reactions and Process factors 
demonstrated good convergent validity with the intended measures, as evidenced by small-
moderate significant correlations with parent-rated anxiety severity, impairment, and clinician-
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rated anxiety, while the Inconvenience (r = -.02, p = .86) and Stigma (r = .10, p = .36) factors 
demonstrated minimal to no relationships with these measures. Of SCAS-P subscales, only panic 
symptoms were significantly related to TWQ-P total scores (r = .24, p = .02), while OCD, Panic, 
and GAD subscales correlated with the Adverse Reactions factor, and Social and Panic 
correlated with the Process factor. Parent treatment worries were not significantly correlated with 
treatment expectancy (TEQ-P; r = -.17, p = .11), which held true across factors.   
Table 10. Convergent Validity of the TWQ-P 
 Parent-Rated Child Anxiety Anxiety 
Impairment 
Treatment 
Expectancy 
Clinician-Rated 
Anxiety  Total  Separation Social OCD Panic Injury GAD 
Total .27* .12 .19 .20 .23* .05 .20 .38** -.17 .22* 
Inconvenience -.02 -.11 .071 .052 .01 -.05 -.07 .15 -.07 .04 
Adverse .32** 0.16 0.17 .30** .26* -.01 .26* .38** -.14 .29** 
Stigma .10 .05 .09 -.03 .11 .04 .11 .13 -.10 -.05 
Process .30** .16 .22* .16 .23* .19 .17 .41** -.19 .30** 
* p < .05; ** p < .001 
 
Divergent validity was assessed by examining Pearson correlation coefficients between 
the TWQ-C and scales of externalizing symptoms, social desirability ratings, and frequency of 
physical exercise (see Table 11). Hypotheses for divergent validity were confirmed, with the 
TWQ-P exhibiting small correlations with frequency of physical exercise (r = .07, p = .54), 
parental ratings of social desirability (r = .12, p = .25), and externalizing symptoms (r = .04, p = 
.72). This was largely consistent across factors. 
Table 11. Divergent Validity of the TWQ-P  
 Social Desirability 
Externalizing Symptoms Exercise 
Total ADHD ODD  
Total .12 .04 .10 -.01 .07 
Inconvenience -.02 .21 .17 .14 -.07 
Adverse .14 -.01 .05 -.02 -.02 
Stigma .17 -.11 .03 -.17 .21* 
Process -.01 .13 .10 .10 .01 
* p < .05; ** p < .001 
 
Exploratory Aim 1. Exploration of variables that may influence the nature and extent of 
treatment concerns was completed using t-tests and Pearson correlation coefficients. In 
particular, TWQ-C scores were examined for their relationship to child age, gender, anxiety 
sensitivity, patient insight, avoidance, and extent of family accommodation. Parent treatment 
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worries did not different significantly between male and female children (t (90) = .39, p = .69) or 
mothers and fathers (t (87) = 1.26, p = .21), and was not associated with child age (r = -.05, p = 
.62). Past psychotherapy was also not associated with parent worries (t (90) = -.18, p = .86), nor 
was medication status (t (90) = -1.10, p = .27).   
Regarding total score, parental treatment worries were moderately correlated with parent 
depression (r = .35, p = .001), and exhibited small correlations with family accommodation (r = 
.23, p = .03) and parent stress (r = .25, p = .02). In general, parent correlates were variable across 
treatment worries factors (see Table 12). Consistent with the total score, the Process factor 
exhibited moderate correlations with family accommodation, and small correlations with 
parental depression; however, it was also the only scale to demonstrate a significant relationship 
to parent-rated child avoidance (r = .35, p = .001) and clinician-rated insight (r = .30, p =.006). 
The Adverse Reactions factor demonstrated small correlations with family accommodation and 
parent depression. Conversely, the Inconvenience factor did not correlate with family 
accommodation, but did exhibit moderate correlations with parent depression, and parent stress. 
The Stigma factor only showed a small correlation with parent depression.  
Table 12. Exploratory Clinical Correlates of the TWQ-P  
 Age Anxiety Sensitivity Avoidance 
Family 
Accommodation Insight 
Parent 
Depression 
Parent 
Anxiety 
Parent 
Stress 
Total -.05 .17 .19 .23* .19 .35** .14 -.05 
Inconvenience .07 .08 .07 -.05 -.08 .30** .09 .28** 
Adverse -.06 .20 .06 .24* .19 .28** .10 -.06 
Stigma -.08 .09 .16 .06 .10 .23* .10 -.08 
Process -.05 .05 .35** .35** .30** .23* .11 -.05 
 
 
Inter-rater Correspondence 
Exploratory Aim 2. Exploration of the correspondence between the TWQ-C and TWQ-P 
factors was conducted using Pearson correlation coefficients to examine item correspondence. 
Item correlations ranged from no relationship (item 10: r = .07, p = .50) to moderately correlated 
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(item 8: r = .43, p <.0001). Using child-determined factors, correlations were examined between 
factors. Parents and children agreed most on the Difficulty factor (r = .45, p <.001), followed by 
Failure (r = .31, p = .003), and Stigma (r = .22, p = .03). All items are presented in Table 13.  
Table 13. Inter-rater Correlations between Matched Items of the TWQ 
  CF PF r p 
1  …therapy is going to make me miss too much school or other important activities outside of school 
(clubs, sports, lessons, etc). D I .29 .007 
2  …if I don’t get better, I’ll feel more frustrated, upset, or embarrassed about my problems than I do 
now.  F A .32 .002 
3  …therapy will be too hard. D A .35 .001 
4  …if I go for therapy, people might think my problems are bigger than they really are. S S .23 .03 
5  …therapy won’t help me. F A .14 .20 
6  …my therapist won’t understand me or my problems. D S .24 .02 
7  …if people find out I’m in therapy, it could be bad for my life (get teased, ruin my future). S S .09 .37 
8  …therapy will be really upsetting.                                                              D A .43 <.001 
10  …starting therapy means that there is really something wrong with me. S S .07 .50 
12  …even if therapy helps, my problems will just come back. F A .18 .09 
13  …if I don’t get better during therapy, my problems will never go away.  F A .25 .015 
14  …going for therapy will make me feel embarrassed. S S .21 .048 
CSS = Child Factor; PSS = Parent Factor; D = Difficulty; F = Failure; S = Stigma; I = Inconvenience; A = Adverse Reaction  
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Discussion 
Anxiety disorders are common and impairing conditions in youth (Kessler et al., 2012; 
Alfano et al., 2007; Conelea et al., 2011; Mychailyszyn et al., 2010; Storch, Larson, et al., 2010). 
Although CBT has demonstrated considerable efficacy in treating these conditions, a significant 
portion of youth fail to demonstrate adequate or optimal response (In-Albon & Schneider, 2007; 
Pediatric, 2004; Walkup et al., 2008). Initial evidence suggests that treatment worries, which can 
be defined as worries regarding involvement, requirements, aspects, and consequences of 
treatment, relate to a number of clinical factors associated with reduced treatment response 
(Selles et al., 2013; Wu et al., 2015). These results suggested that treatment worries may be an 
important understudied construct and warrant further investigation; however, they relied on 
disorder-specific questionnaires directly translated from an adult version, and therefore were 
limited in the breadth of their potential use, failed to capture worries that may be unique to 
youth, and lacked investigation of parental worries.  
Therefore, the present study examined the initial outcomes and psychometric properties 
of the TWQ-C and TWQ-P: brief non-disorder/treatment specific scales developed to evaluate 
concerns about initiating psychosocial treatment in both youth and their parent. For this initial 
evaluation, participants were youth aged 7-17, along with their primary parent (i.e., the one 
present or the one planning to be primarily involved in treatment), who were presenting for CBT 
for an anxiety disorder at one of two specialty outpatient clinics. The final sample of 94 
contained 62% females and 88% mothers with an average patient age of 12.31 years.  
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Treatment Worries Questionnaire – Child Version 
Outcomes of the TWQ-C were consistent with prior studies of treatment worries (Rowa 
et al., 2014; Selles et al., 2013; Wu et al., 2015), with low levels of worries reported on average, 
but moderate levels of concern for a small portion of youth. Some concerns were generally 
viewed as problematic by much of the sample. Specifically, items 2 (“if I don’t get better, I’ll 
feel more frustrated, upset, or embarrassed about my problems than I do now”), 13 (“if I don’t 
get better during therapy, my problems will never go away”), and 17 (“I will have to talk about 
things I don’t want to talk about”), were endorsed in the mild-moderate range and had a sizeable 
portion of responders who endorsed one of the highest two response options. Of the 20 initial 
items, 17 items had >10% of the sample endorse one of the highest two response options, 
suggesting most items had salience for at least a portion of youth. Three items, which focused on 
treatment making things worse (i.e., 9, 11, 15), were not frequently endorsed and were removed 
from the scale.  
The TWQ-C exhibited a three factor solution with good item-factor loadings. The largest 
factor with eight items, Difficulty, focused on worries associated with treatment being 
inconvenient, being hard/upsetting, and involving things the child does not want to do. Five 
items loaded onto the Stigma factor, which focused on worries around how personal or external 
perceptions of mental health/treatment could impact their lives if they complete treatment. 
Finally, four items loaded onto the Failure factor which focused on worries associated with 
consequences of treatment not effectively improving symptoms. This was also the factor with the 
highest average item mean, indicating it is the most prominent area of concern for these youth. 
The factors were also all highly correlated with each other suggesting that they tap into a 
consistent underlying construct.  
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Psychometric outcomes for the TWQ-C were favorable. The scale, and identified factors, 
exhibited good to excellent internal consistency (a = .87 - .92) and test-retest reliability (r = .86 - 
.92).  Convergent validity for the TWQ-C was evident through moderate positive correlations 
with child-ratings of anxiety severity and treatment expectancy. The relationship between 
treatment expectancy and treatment worries in children is not surprising. Children who do not 
expect treatment to be effective are likely concerned about it failing and/or more likely to view it 
as not worth the effort. Child ratings were not correlated with child-ratings of anxiety-related 
impairment, which suggests that while worries are associated with the number and frequency of 
anxiety symptoms, they are not impacted by the extent to which symptoms interfere with the 
child’s life. Divergent validity for the TWQ-C was established by small and non-significant 
correlations with child’s frequency of physical exercise, ratings of social desirability, and parent-
ratings of externalizing symptoms, which was also consistently observed across factors.   
Regarding additional clinical correlates, the TWQ-C exhibited strong associations with 
anxiety sensitivity. The relationship between anxiety sensitivity and treatment worries was also 
expected. Children who are particularly bothered by their experiences of anxiety, or who 
experience physical symptoms more often, may view the idea of exposure therapy as more 
aversive and as a result be more worried about initiating treatment. In addition, they may be 
more concerned about treatment failure as this would result in a continuation of what they 
perceive as highly disturbing experiences. The TWQ-C, particularly the Failure factor, was also 
mildly associated with age. The correlation between this factor and age may suggest that as 
youth age, they become more concerned about the potential that their symptoms may not 
improve or remit. This worry may be realistic for youth given that intensity of symptoms tends to 
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increase with age (Selles, Storch, & Lewin, 2014) and increased symptom severity is associated 
with reduced treatment response (Garcia et al., 2010).  
Surprisingly, patient insight was not related to level of treatment worries. This may be 
due to a non-relationship between these factors, but also could be a result of differing 
interpretations of treatment within insight levels. For example, one could theorize that patients 
with low insight would be highly worried about treatment because they can’t grasp why it would 
help and don’t think they need it. On the other hand, patients with minimal insight may simply 
be detached from the whole therapeutic process and exhibit little thought or concern over it at all. 
Similarly, patients with good insight could be concerned about the prospect of treatment failure 
because they understand how problematic their symptoms are, or, on the other hand, may have 
less concerns because they can more easily grasp why/how treatment is likely to be helpful. The 
other explored clinical correlates, specifically child avoidance, family accommodation, and 
parental depression, stress, and anxiety, also did not demonstrate meaningful relationships with 
treatment worries. The non-relationships in many of these variables may be a further reflection 
of the lack of a relationship between treatment worries and anxiety-related impairment, as many 
of these additional correlates were related to the impact of the child’s symptoms on their life 
(e.g., avoidance, family accommodation); however, it may also be a reflection of the fact that, 
other than avoidance, these additional explored correlates were rated by the parent rather than the 
child. 
 
Treatment Worries Questionnaire – Parent Version 
Parent responses on the TWQ-P indicated lower levels of treatment concern and less 
variability in scores than seen in children. Mean item endorsement and percentage of top tier 
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responders were generally consistent, with the highest endorsed concerns falling in the mild-
moderate range and focused on consequences should symptoms remain following treatment (e.g., 
items 2, 13). Beyond these, the majority of remaining items were either infrequently or 
minimally endorsed, including 13 items with item means in the no concerns range. While items 
that also fell within this range on the TWQ-C (i.e., 9, 11, 15) along with item 25 (which shared 
the same theme) were removed, the other infrequently endorsed items were retained with the 
belief that these items may still be relevant for the measure in alternate samples.  
Metrics used in the exploratory factor analysis of the TWQ-P did not strongly point to 
any specific factor solution; however, examination of item loadings suggested that a four-factor 
solution retained all remaining items with largely acceptable factor loadings and minimal cross-
loadings. The largest factor with 8 items was Adverse Reactions, which focuses on worries 
related to the emotional consequences of treatment or treatment failure. The Stigma scale 
contained the same four matched items as were identified for the TWQ-C Stigma factor, but also 
included matched item 6 (i.e., my therapist won’t understand my child or my child’s symptoms), 
which loaded onto the Difficulty factor for children, Given that the question reflects an external 
rather than internal evaluation for the parent as compared to the child, this difference is 
understandable. Finally, a four item factor labeled Inconvenience, which focuses on worries 
related to managing the demands of treatment and its value, as well as a four item factor labeled 
Process, which focused on worries related to how the child and/or parent will experience aspects 
of therapy (e.g., low motivation, seem like bad parent) were identified. Correlations between 
factors varied, with the Inconvenience factor demonstrating the weakest association with the 
other factors.  
 44 
Psychometric outcomes for the TWQ-P were moderately supported, although not to the 
same extent as observed for the TWQ-C. The scale exhibited good internal consistency and 
acceptable test-retest reliability for the total score, while factors varied from questionable to good 
in regards to internal consistency (a = .67 - .85) and test-retest reliability ((r = .61 - .81). 
Convergent validity for the TWQ-P total score was evident through moderate positive 
correlations with parent-ratings of anxiety impairment, but not through relationships with parent-
rated child anxiety severity or treatment expectancy. However, when factors were examined it 
became evident that two factors, Adverse Reactions and Process, were correlated with these 
variables, while Stigma and Inconvenience were not. Along with the reduced relationships 
between factors reported above, this suggests that in contrast to children, treatment worries may 
not represent a unitary overall construct in parents. Given the nature of the worries addressed in 
the Inconvenience and Process factors are primarily around the decision to engage in treatment at 
all, this finding is not particularly surprising. As a treatment seeking sample, this decision to 
complete treatment is true across the levels of the child’s severity, resulting in the lack of 
relationship observed between these factors. For example, while more severe symptoms may 
have initially increased the parent’s perceived need for treatment (leading them to present for 
treatment), it would not necessarily impact their perceived ability to meet the demands of 
therapy. Regardless, alternative constructs (e.g., parental perceptions of mental illness, parent-
rated availability) may serve better as measures of convergent validity for these factors. 
Divergent validity for the TWQ-C was supported by small and non-significant correlations with 
child’s frequency of physical exercise, as well as parent-ratings of externalizing symptoms and 
social desirability.   
 45 
Regarding additional clinical correlates, outcomes varied in their consistency across 
factors of the TWQ-P. Child age, anxiety sensitivity, and parent-rated anxiety were consistently 
not related to treatment worries, while parent-rated depressive symptoms were consistently 
associated at small-moderate levels. The Process factor was consistently related to parent-rated 
aspects of the child’s anxiety profile, including relationships with avoidance, family 
accommodation, and insight. These correlations may simply reflect this factor’s general 
association with parent-rated child impairment; however, these unique relationship are consistent 
with the factors themes as these correlates would be expected to lead to increased problems 
regarding child honesty (e.g., insight), child effort (e.g., avoidance), and the parent being mean/a 
poor parent (e.g., family accommodation). Similarly the relationships observed for the 
Inconvenience factor support its convergent validity as child aggressive behavior, low parental 
energy and mood, and parental stress levels would all be expected to increase the difficulty in 
meeting the demands of treatment. The Stigma factor was only minimally correlated with 
parental depression, while the Adverse Reaction factor demonstrated relationships consistent 
with the total score. In future examinations, inclusion of scales that measure stigma and mental 
health perceptions more broadly would be beneficial in establishing the convergent validity of 
this factor.  
 
Inter-rater Correspondence  
 The agreement between children and parents varied considerably across items. Upon 
examination it appears that items relating to the emotional experience of the child (e.g., 2, 3, 8) 
were more likely to be consistently rated, while items that reflect the potential impact of stigma 
associated with treatment appeared the least agreed upon. The variability in agreement may be a 
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reflection of the extent to which the item assesses worries related to a more objective 
phenomenon (e.g., emotional reactivity, treatment’s impact on other activities) compared to a 
more personally held perception or belief (e.g., engaging in treatment means there is something 
really wrong with me/my child). Given that inter-rater agreement is not perfect even for 
equivalent rating scales (e.g., SCAS-C, SCAS-P; Nauta et al., 2004), it is not particularly 
surprising that children and parents do not exhibit total agreement on related but personally-
focused items.  
 
Implications of Findings 
Treatment concerns were endorsed at mild to moderate levels in the majority of children. 
Given this, treatment concerns appear to be a relevant construct in this population and for those 
who experience them at greater levels, specific intervention of these concerns may be warranted. 
For example, psychoeducation focused on addressing concerns over treatment failure, discussion 
of treatment alternatives, and normalization of symptoms and therapy process, may help alleviate 
concerns. Implementation of motivational interviewing techniques may also increase buy-in and 
reduce concerns. Given the relationship between treatment expectancy and treatment worries in 
children, setting up realistic treatment expectations may also be useful in reducing the level of 
worry.  
While the focus of the present studies analyses has been primarily on mean level ratings 
and outcomes, individual response profiles may be equally, or more, important to consider in 
attempting to determine which youth/parents may benefit from specialized intervention. For 
example, two children could demonstrate the same total scores in the mild range; however, a 
child whose score is comprised of mild endorsement of all items may be less in need of 
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intervention than a child who exhibits minimal overall endorsement but high endorsement of 
select items. As a result, clinical use of the TWQ will likely be most effective if children’s and 
parent’s responses are analyzed on both item and subscale/total score levels.  
Outside of the few items related to worries about the child not experiencing symptom 
improvement, the low level of concerns reported by parents suggest that they are generally 
comfortable with the idea of treatment and are on board for engaging in therapeutic processes. 
This lack of worry about treatment within parents has several implications for practice: 1) 
treatment components can be quickly initiated without overwhelming parents; 2) parents require 
little direct addressing or intervention in regards to treatment engagement; 3) if treatment 
engagement/compliance is low, other factors may be at play (e.g., poor insight, low treatment 
expectancy, family conflict/other situational stressors); and 4) parents may be employed to 
model confidence in treatment and alleviate child worries. 
Despite this, the low levels of treatment worries endorsed by parents may be a direct 
reflection of their decision to seek treatment, as compared to other parents of anxious youth who 
have not yet done so. As a result, in contrast to parents who have not yet sought treatment for 
their child, these parents, may: 1) have always held less worries about treatment, increasing their 
likelihood to attend; 2) have resolved their worries through research or consultation prior to 
attending treatment; and/or 3) have experienced or continue to experience some worries, but 
suppress(ed) them in connection with the decision to seek help (cognitive dissonance/action 
stage). This may also be true for some youth, particularly those who have contributed to the 
decision to attend treatment. If so, it may be expected that youth who have not been brought to 
treatment by their families also exhibit greater levels of treatment worries. Regardless, 
examination of treatment worries in a sample of families of youth with clinical symptoms who 
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have not yet presented for psychosocial treatment (e.g., primary care clinic) is of great interest. 
Given that many individuals delay seeking, or do not seek, treatment (Wang et al., 2007; Wang 
et al., 2005) and untreated pediatric anxiety disorders have a host of negative outcomes (e.g., 
Alfano et al., 2007; Mychailyszyn et al., 2010; Storch, Larson, et al., 2010), examination of 
treatment worries as a potential treatment barrier is warranted.  
While families actively transferring from current treatment (e.g., stepping down from 
intensive treatment) were excluded, prior treatment and current pharmaceutical treatment were 
not exclusionary. As a result, some families may have already been through the therapeutic 
process which likely contributed to the extent and domains of their reported worries. This could 
be in a positive (e.g., we know treatment works and are less worried) or negative direction 
(treatment hasn’t worked in the past, so why will it now). The sample also differs from families 
seeking, or in need of, treatment for other forms of psychopathology as well as families in which 
the child begins therapy for reasons other than their own decision (e.g., inpatient admission, 
court-mandated treatment). The TWQ was developed with these alternative uses in mind, and the 
psychometric outcomes and factor structures observed in the present sample/population support 
and serve as a guide for its continued use; however, these outcomes should be reexamined when 
used in these distinct populations.   
Due to the infrequency of both parents attending treatment sessions, only one parent 
report of treatment worries was examined in the present study. While the presentation of only 
one parent at treatment may have frequently been the result of personal limitations (e.g., time off 
work), clinical experience has also suggested that non-attending parents may have less 
therapeutic buy-in. As a result, the non-attending parent may exhibit a unique set, or differing 
levels, of treatment concerns. In the decision to obtain treatment and in the delivery of treatment, 
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‘non-supportive’ absent parents can be problematic, as they may create stress/ambivalence for 
the treatment-seeking parent, continue to engage in anxiogenic strategies (e.g., accommodation), 
and may contribute to poor engagement/compliance in the child. Attempting to obtain a 
secondary parent/care-giver report would be beneficial in further examining the prevalence and 
impact of treatment worries and would provide interesting information regarding the level of 
agreement between parents on this topic. 
While past examinations of treatment concerns have not supported a relationship with 
treatment outcome, the possibility of treatment concerns affecting outcome through engagement, 
compliance, and withdrawal remains. In particular, one could theorize that concerns over 
difficulty or stigma may be particularly damaging to a patient’s engagement as they may feel that 
treatment is too much of a hassle or may put them at to great of risk. However, it could also be 
suggested that a small level of treatment concern over failure may be protective, in that children 
and parents may be motivated to engage in treatment components to ensure their success. A large 
degree of worry over treatment failure may be problematic in that families may worry that they 
are powerless to change and may ruminate on the prospect of failure rather than working towards 
acceptance and change. Regardless, further examination of treatment worries within the context 
of treatment completion and outcome is warranted. 
 
Study Strengths and Limitations 
The present study has a number of strengths. First, the study includes a relatively large 
and well characterized sample of anxious youth and their primary parent, including dyads from 
two geographically distinct regions. Second, the study included a wide range of secondary 
measures that spanned both self, parent, and clinician reports, providing additional information 
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regarding the clinical profile of treatment worries and differences in agreement. Finally, the 
recruitment method of consecutive referrals of youth presenting for treatment provides a 
relatively representative sample of individuals presenting for treatment.  
The study’s findings should be considered within the context of its limitations. First, 
while including non-specific treatment items allows the TWQ greater future flexibility, it limits 
the conclusions of the present study, in that findings regarding treatment worries cannot be 
considered specific conclusions about any specific treatment components, such as exposures. 
Second, as mentioned in the discussion, the measures were examined in a treatment-seeking 
sample of youth with anxiety disorders, along with one of their parents, many of whom had 
previously completed psychosocial treatment and/or were on psychiatric medications. Therefore, 
the outcomes described cannot be assumed for other populations.  
 
Conclusions  
 Prior to the present study, treatment worries in children had only been examined using 
disorder specific measures and no measure had examined the concept in parents. The results of 
the present study strongly support the psychometric properties of the TWQ-C as an assessment 
of treatment worries not tied to any disorder or treatment and suggest that treatment worries are a 
relatively common phenomenon at mild-moderate levels in anxious/OCD youth. In addition, the 
results tentatively support the TWQ-P as an assessment of treatment worries amongst parents, 
although infrequent endorsement of items, likely related to the treatment-seeking nature of the 
sample, limits the strength of these outcomes. Overall, the results of the present study support the 
future use of the TWQ-C and TWQ-P to examine treatment worries in a diverse set of 
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populations including: those who exhibit any range of psychological problems; those who are 
treatment naïve; those not yet seeking treatment; and those in mandated treatment.  
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Appendix B. Mayo Approval Letter 
 
Principal	Investigator	Notification:	
Re:	 IRB	Application	#:	14-003737	
	 Title:	Psychometric	Evaluation	of	the	Beliefs	about	Accommodation	Scale	and	Treatment	Worries	Questionnaire	
													IRBe	Protocol	Version:	0.01	
													IRBe	Version	Date:	7/2/2014	7:42	AM	
													IRB	Approval	Date:	7/3/2014	
													IRB	Expiration	Date:	7/2/2015	
	
The above referenced application is approved by expedited review procedures (45 CFR 46.110, item 5, 
7). This approval is valid for a period of 1 year. The Reviewer conducted a risk-benefit analysis, and 
determined the study constitutes minimal risk research. The Reviewer determined that this research 
satisfies the requirements of 45 CFR 46.111. The Reviewer determined there is adequate justification for 
participation of children in the research   as set forth in 45 CFR 46.404 (Subpart D). The questionnaires 
were reviewed and approved as written.	
 	
The written consent and assent forms were reviewed and approved with revisions. Assent is required from 
subjects ages 7 to 17. Assent shall be documented by a separate written assent form for subjects ages 7 to 
12 and by signature on the consent form for subjects ages 13 to 17. The permission of one parent is 
required.	
 	
AS THE PRINCIPAL INVESTIGATOR OF THIS PROJECT, YOU ARE RESPONSIBLE FOR THE 
FOLLOWING RELATING TO THIS STUDY.	
1)   When applicable, use only IRB approved materials which are located under the documents tab of the 
IRBe workspace.  Materials include consent forms, HIPAA, questionnaires, contact letters, 
advertisements, etc.	
2)  Submission to the IRB of any modifications to approved research along with any supporting 
documents for review and approval prior to initiation of the changes.	
3)  Submission to the IRB of all Unanticipated Problems Involving Risks to Subjects or Others 
(UPIRTSO).	
4)  Compliance with Mayo Clinic Institutional Policies.    	
	
Mayo	Clinic	Institutional	Reviewer 
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Appendix C. Demographic Form 
 
PARENTAL INFORMATION 
1. Person filling out this form:   1 = Mother    2 = Father 3 = Other: _________________ 
 
2. Parent Age:     
 
3.  Estimate total household income, including all sources    
 1 = $0 - $19,999  3 = $40,000 - $59,999  5 = $80,000 - $99,999 
 2 = $20,000 - $39,999  4 = $60,000 - $79,999  6 = over $100,000  
 
 
CHILD INFORMATION 
4. Child's Date of Birth:             Age: _______ 
    Month                    Day                        Year 
            
5. Gender: 1 = Female  2 = Male  
 
6. Child Ethnicity:       
 1 = White (non-Hispanic)   5 = Native American 
 2 = African-American (non-Hispanic)  6 = Pacific Islander 
 3 = Hispanic/Latin American   7 = Middle Eastern 
 4 = Asian     8 = Other (specify): ____________________ 
 
7. Living Situation:     
 1 = Lives with both biological parents (same residence) 
 2 = Lives with both biological parents (different residences – shared custody) 
 3 = Lives with single parent: Mother  6 = Lives with Father and Stepmother 
4 = Lives with single parent: Father  7 = Lives with Grandparents  
5 = Lives with Mother and Stepfather  8 = Other (specify):______________________ 
 
8. Number of participant’s siblings also within home (include adopted and step-siblings)   
 
SCHOOL INFORMATION 
 
9. This child attends: 1 = PUBLIC school 2 = PRIVATE school 3 = HOME schooled    
 
10.  Current Grade (or last grade completed if in summertime): __________ 
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PSYCHOTHERAPY HISTORY 
 
11.   Has your child ever been treated for emotional/psychiatric/behavioral problems with therapy? 
0 =  NO  1 = YES 
If YES, please complete the following: 
Approximate 
Start and End 
Date/Child Age 
Problems 
Addressed  
Type of 
Therapy if 
Known 
Parent 
Involvement: (0 =  
not involved – 5 = 
highly involved) 
Reason for 
stopping/Response 
(poor, fair good) 
 
 
    
 
 
    
 
 
    
 
MEDICATION STATUS 
12.   Is your child currently treated for emotional or psychiatric problems with medication? 
0 = NO  1 = YES 
If YES, please complete the table below: 
MEDICATION Dose (per day) Start Date Diagnosis 
Response 
(poor, fair, good) 
Side 
Effects 
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Appendix D. Treatment Worries Questionnaire – Initial Child Version 
 
↓ INSTRUCTIONS ↓ 
This is a list about different worries that kids may have about starting therapy. Some kids may have a lot of these 
worries, while others kids may have some or none.  
 
Please circle how worried you are about what each line says. 
               
Not Worried Moderately Worried Very Worried 
0 1 2 3 4 5 
 
I WORRY THAT… Not  Worried 
Very 
Worried  
1  …therapy is going to make me miss too much school or other important 
activities outside of school (clubs, sports, lessons, etc). 0 1 2 3 4 5 
2  …if I don’t get better, I’ll feel more frustrated, upset, or embarrassed about 
my problems than I do now.  0 1 2 3 4 5 
3  …therapy will be too hard. 0 1 2 3 4 5 
4  …if I go for therapy, people might think my problems are bigger than they 
really are. 0 1 2 3 4 5 
5  …therapy won’t help me. 0 1 2 3 4 5 
6  …my therapist won’t understand me or my problems. 0 1 2 3 4 5 
7  …if people find out I’m in therapy, it could be bad for my life (get teased, 
ruin my future). 0 1 2 3 4 5 
8  …therapy will be really upsetting.                                                              0 1 2 3 4 5 
9  …therapy will make me have new problems.                                         0 1 2 3 4 5 
10  …starting therapy means that there is really something wrong with me. 0 1 2 3 4 5 
11  …therapy will make me change in ways I won’t like.  0 1 2 3 4 5 
12  …even if therapy helps, my problems will just come back. 0 1 2 3 4 5 
13  …if I don’t get better during therapy, my problems will never go away.  0 1 2 3 4 5 
14  …going for therapy will make me feel embarrassed. 0 1 2 3 4 5 
15  …therapy will make my problems worse.                                                        0 1 2 3 4 5 
16  …therapy is going to take up time I could spend doing things I like. 0 1 2 3 4 5 
17  …I will have to talk about things I don’t want to talk about. 0 1 2 3 4 5 
18  …therapy will make me change things I don’t want to change. 0 1 2 3 4 5 
19  …therapy will make me change how I deal with my problems and I’ll lose 
control.  0 1 2 3 4 5 
20  …if I don’t get better during therapy, my parent(s) will be disappointed in 
me.  0 1 2 3 4 5 
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Appendix E. Treatment Worries Questionnaire – Initial Parent Version 
 
↓ INSTRUCTIONS ↓ 
This questionnaire asks about how you currently feel about your child starting therapy. Starting therapy can be 
accompanied by a number of different emotions and expectations. While some parents may have no concerns about 
therapy, others may worry about what therapy will result in or require.  
 
Please circle how worried you are about each of the following. 
               
Not Worried Moderately Worried Very Worried 
0 1 2 3 4 5 
 
I WORRY THAT… Not 
Worried 
Very 
Worried 
1  …therapy is going to get in the way of my child’s education or extracurricular 
activities. 0 1 2 3 4 5 
2  …if therapy doesn’t work, my child will feel more frustrated, upset, or 
embarrassed about their symptoms than they already do. 0 1 2 3 4 5 
3  …therapy will be too hard for my child. 0 1 2 3 4 5 
4  …if my child goes for therapy, people might think his/her problems are bigger 
than they really are. 0 1 2 3 4 5 
5  …therapy won’t help my child. 0 1 2 3 4 5 
6  …my child’s therapist won’t understand my child or my child’s symptoms. 0 1 2 3 4 5 
7  …if people find out my child is in therapy, it could negatively impact my child’s 
life (e.g., be teased, ruin future opportunities). 0 1 2 3 4 5 
8  …therapy will be upsetting for my child. 0 1 2 3 4 5 
9  …therapy will somehow result in new symptoms. 0 1 2 3 4 5 
10  …starting my child in therapy means admitting there is something wrong with 
him/her. 0 1 2 3 4 5 
11  …therapy will change my child in ways he/she won’t like. 0 1 2 3 4 5 
12  …even if therapy helps, my child’s symptoms will return. 0 1 2 3 4 5 
13  …if therapy doesn’t work, my child’s symptoms will never go away. 0 1 2 3 4 5 
14  …going for therapy will make my child feel embarrassed. 0 1 2 3 4 5 
15  …therapy will make my child’s symptoms worse.                                                        0 1 2 3 4 5 
16  …therapy will be a waste of time and money. 0 1 2 3 4 5 
17  …my child won’t be honest in therapy. 0 1 2 3 4 5 
18  …my child’s therapist will think I’m a bad parent. 0 1 2 3 4 5 
19  …therapy is going to get in the way of my personal responsibilities (e.g., work, 
family). 0 1 2 3 4 5 
20  …therapy may put my child’s privacy at risk. 0 1 2 3 4 5 
21  …meeting the logistic demands of therapy (e.g., scheduling, cost, 
transportation) will be too difficult. 0 1 2 3 4 5 
22  …if therapy doesn’t work, I will feel more frustrated, upset, or embarrassed 
about my child’s symptoms than I already do. 0 1 2 3 4 5 
23  …if therapy doesn’t work, we will have to try methods of treatment I am not as 
comfortable with (medication, hospitalization, etc). 0 1 2 3 4 5 
24  …my child will not make an effort to improve during therapy. 0 1 2 3 4 5 
25  …therapy will make my child change in ways I won’t like. 0 1 2 3 4 5 
26  …therapy will require me to act in ways that will upset my child or make my 
child think I am mean. 0 1 2 3 4 5 
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Appendix F. Measure of Insight 
 
Measure of Insight  
 
Rate the patient’s insight into the senselessness or excessiveness of his/her symptoms. Please review the child’s 
anxiety symptoms before attempting to answer this question.  
 
Prompts (use any or all):  
1. How sure are you of your worries or fears?   
2. Do you feel that your concerns and behaviors are reasonable or do they seem excessive?  
3. What do you think other kids or people (would) think of your beliefs/worries? [PAUSE] How certain are 
you that most people think your beliefs make sense?  
4. If I were to try to prove your worries or beliefs wrong, how would you feel? Do you think you could be 
convinced?  
5. Why do you think you have these fears/worries/beliefs? [PAUSE] Are they because of a psychological 
symptom, or are they actually true/necessary? 
6. Do you think being scared/afraid/worried makes things better or keeps you safe?  
  
0 Excellent Insight 
Fully rational 
1 Good Insight 
Readily acknowledges absurdity of thoughts or behaviors but does not seem completely 
convinced that there isn’t something besides anxiety to be concerned about (i.e., has 
lingering doubts) 
2 Fair Insight Reluctantly admits thoughts or behavior may seem unreasonable or excessive, but wavers; may have some unrealistic fears, but no fixed convictions 
3 Poor Insight 
Maintains that thoughts or behaviors are not excessive or unreasonable, but wavers; may have 
some unrealistic fears, but acknowledges validity of contrary evidence (i.e., 
overvalued ideas present) 
4 No Insight 
Delusional, definitely convinced that concerns and behavior are reasonable, unresponsive to 
contrary evidence 
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Appendix G. Description of Cognitive Behavioral Therapy 
 
The treatment you are interested in receiving is named cognitive behavioral therapy or 
CBT. It is the best treatment we have for treating anxiety disorders. By the end of treatment, 
most kids’ anxiety symptoms are much better. While it does work well for most kids, some kids 
don’t get better. While kids are the focus of the treatment, parents are highly involved and help 
the child complete treatment homework.   
 
CBT involves the following components:  
à At the start of CBT, your therapist will teach you about what anxiety is, what 
contributes to anxiety, how CBT helps fight back anxiety, and what will be expected of you 
during treatment.  
à During CBT you will develop a list of things (situations, people, objects) that are 
scary to you. You will rank these items in a list from least scary to most scary. Then, starting at 
the bottom of the list and slowly working your way up, your therapist will help you start to face 
the things that scare you without doing things that make you feel better (e.g., running away, 
compulsions, reassurance).  
à At the end of treatment, your therapist will work with you to come up with strategies 
to help you keep (or continue to make) improvements and to fight back against new symptoms if 
they arise after treatment is over.  
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Appendix H. Treatment Worries Questionnaire – Revised/Final Child Version 
 
↓ INSTRUCTIONS ↓ 
This is a list about different worries that kids may have about starting therapy. Some kids may have a lot of these 
worries, while others kids may have some or none.  
 
Please circle how worried you are about what each line says. 
               
Not Worried Moderately Worried Very Worried 
0 1 2 3 4 5 
 
I WORRY THAT… Not  Worried 
Very 
Worried  
1  …therapy is going to make me miss too much school or other important 
activities outside of school (clubs, sports, lessons, etc). 0 1 2 3 4 5 
2  …if I don’t get better, I’ll feel more frustrated, upset, or embarrassed about 
my problems than I do now.  0 1 2 3 4 5 
3  …therapy will be too hard. 0 1 2 3 4 5 
4  …if I go for therapy, people might think my problems are bigger than they 
really are. 0 1 2 3 4 5 
5  …therapy won’t help me. 0 1 2 3 4 5 
6  …my therapist won’t understand me or my problems. 0 1 2 3 4 5 
7  …if people find out I’m in therapy, it could be bad for my life (get teased, 
ruin my future). 0 1 2 3 4 5 
8  …therapy will be really upsetting.                                                              0 1 2 3 4 5 
9 …starting therapy means that there is really something wrong with me. 0 1 2 3 4 5 
10  …even if therapy helps, my problems will just come back. 0 1 2 3 4 5 
11  …if I don’t get better during therapy, my problems will never go away.  0 1 2 3 4 5 
12  …going for therapy will make me feel embarrassed. 0 1 2 3 4 5 
13  …therapy is going to take up time I could spend doing things I like. 0 1 2 3 4 5 
14  …I will have to talk about things I don’t want to talk about. 0 1 2 3 4 5 
15  …therapy will make me change things I don’t want to change. 0 1 2 3 4 5 
16  …therapy will make me change how I deal with my problems and I’ll lose 
control.  0 1 2 3 4 5 
17  …if I don’t get better during therapy, my parent(s) will be disappointed in 
me.  0 1 2 3 4 5 
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Appendix I. Treatment Worries Questionnaire – Revised/Final Parent Version 
 
↓ INSTRUCTIONS ↓ 
This questionnaire asks about how you currently feel about your child starting therapy. Starting therapy can be 
accompanied by a number of different emotions and expectations. While some parents may have no concerns about 
therapy, others may worry about what therapy will result in or require.  
 
Please circle how worried you are about each of the following. 
               
Not Worried Moderately Worried Very Worried 
0 1 2 3 4 5 
 
I WORRY THAT… Not 
Worried 
Very 
Worried 
1  …therapy is going to get in the way of my child’s education or extracurricular 
activities. 0 1 2 3 4 5 
2  …if therapy doesn’t work, my child will feel more frustrated, upset, or 
embarrassed about their symptoms than they already do. 0 1 2 3 4 5 
3  …therapy will be too hard for my child. 0 1 2 3 4 5 
4  …if my child goes for therapy, people might think his/her problems are bigger 
than they really are. 0 1 2 3 4 5 
5  …therapy won’t help my child. 0 1 2 3 4 5 
6  …my child’s therapist won’t understand my child or my child’s symptoms. 0 1 2 3 4 5 
7  …if people find out my child is in therapy, it could negatively impact my child’s 
life (e.g., be teased, ruin future opportunities). 0 1 2 3 4 5 
8  …therapy will be upsetting for my child. 0 1 2 3 4 5 
9  …starting my child in therapy means admitting there is something wrong with 
him/her. 0 1 2 3 4 5 
10  …even if therapy helps, my child’s symptoms will return. 0 1 2 3 4 5 
11  …if therapy doesn’t work, my child’s symptoms will never go away. 0 1 2 3 4 5 
12  …going for therapy will make my child feel embarrassed. 0 1 2 3 4 5 
13  …therapy will be a waste of time and money. 0 1 2 3 4 5 
14  …my child won’t be honest in therapy. 0 1 2 3 4 5 
15  …my child’s therapist will think I’m a bad parent. 0 1 2 3 4 5 
16  …therapy is going to get in the way of my personal responsibilities (e.g., work, 
family). 0 1 2 3 4 5 
17  …therapy may put my child’s privacy at risk. 0 1 2 3 4 5 
18  …meeting the logistic demands of therapy (e.g., scheduling, cost, 
transportation) will be too difficult. 0 1 2 3 4 5 
19  …if therapy doesn’t work, I will feel more frustrated, upset, or embarrassed 
about my child’s symptoms than I already do. 0 1 2 3 4 5 
20  …if therapy doesn’t work, we will have to try methods of treatment I am not as 
comfortable with (medication, hospitalization, etc). 0 1 2 3 4 5 
21  …my child will not make an effort to improve during therapy. 0 1 2 3 4 5 
22  …therapy will require me to act in ways that will upset my child or make my 
child think I am mean. 0 1 2 3 4 5 
 
